Subject index to abstracts

Subject Index to Abstracts Abdomen, acute, in liver cirrhosis, PEG-interferon alpha 2B therapy and, 590 Abdominal pain abdominal CT in primary care outpatients, 715 ACE-inhibitor-induced isolated visceral angioedema as cause of, 656 chronic endoscopic pancreatic function test with porcine secretin for evaluation of, 204 Santorinicele and, 629 epiploic appendagitis as cause of, 549 intermittent, C1 esterase deficiency presenting as, 650 intractable, presentation in young woman, 655 metabolic acidosis and, systemic vasculitis presenting with, 497 toothpick ingestion and, 685 traumatic, CA19 –9 and, pancreatic adenocarcinoma diagnosis and, 568 Abdominal wall pain, chronic, in referral practice, 739 Acetaminophen overdose, in pregnancy, case report and literature review, 559 Acetylsalicylic acid, systemic absorption of, 801 Achalasia after cervical spinal injury, 503 as cause of congestive heart failure, 595 development after trauma, 23 evaluation by intraluminal impedance and esophageal manometry, 16 Acid exposure, esophageal abnormality in GERD, 1 in Barrett’s esophagus, PPI effects on, 66 erosive GERD and, 65 evening vs. morning rabeprazole administration effects on control of, 10 heartburn and, 115 motor events and, in noncardiac chest pain, 64 pH monitoring for assessment of, 29 rabeprazole vs. omeprazole effects on, in GERD, 74 Acid reducing agents, use in medical vs. surgical management of gastroesophageal reflux disease, 730 Acid reflux gastroesophageal reflux disease symptoms association with, 45 lansoprazole effects on asthma exacerbations and quality of life in, 39 Acquired immunodeficiency syndrome gastrointestinal histoplasmosis of stomach and colon and, 396 histoplasmosis causing duodenal obstruction as initial presentation of, 635 pneumatosis coli and cryptosporidiosis of GI tract, 513 Adenocarcinoma esophageal, intestinal metaplasia and, international prevalence study, 7 p27 expression in Barrett’s esophagus as marker of, 12 signet cell, of terminal ileum, in neurofibromatosis and Crohn’s disease, 620 surveillance in Barrett’s esophagus effects on survival, 83 Adenoma duodenal as complication of celiac disease, 393 prevalence of, 230 extrahepatic biliary cyst, case report, 616 stool DNA analysis for detection and follow-up of, 332 Adrenal carcinoma, fulminant Budd-Chiari syndrome and, 379 Age, esophagitis severity and esomeprazole/lansoprazole treatment effects, 43 Aging, dysphagia incidence in, 8 Alanine aminotransferase, nonalcoholic fatty liver disease and, 268 Alcohol intake, chronic, bacterial infection in cirrhosis and acute pancreatitis, 224 Alendronate, once-weekly, NSAID and, upper GI tolerability, 158 Alkaline phosphatase, as indicator of liver compromise in amyloidosis, 284 Allium, Helicobacter pylori eradication effects, 161

Allopurinol, ERCP pancreatitis prevention, 921 Ampulla, fibrotic, cholecystokinin-assisted needle knife of, 426 Ampulla of Vater gangliocytic paraganglioma involving, endoscopic resection of, 593 lidocaine spray on, post-ERCP pancreatitis incidence and, 190 refractory celiac disease of, as cause of biliary obstruction and papillary stenosis, 431 Amyloidosis liver compromise in, alkaline phosphatase, triglyceride, and cholesterol levels as indicator of, 284 primary systemic, presenting as cholestatic jaundice and liver failure, 569 secondary, of liver, as primary manifestation of Crohn’s disease, 488 Amyotrophic lateral sclerosis, gastrointestinal symptom prevalence in, 862 Anastomotic strictures after liver transplantation, ERCP evaluation and management role, 282 development after Roux-en-Y gastric bypass procedure, 164 Androgen, long-term use of, hepatocellular carcinoma and pancreatis islet cell tumors and, 564 Anemia iron deficiency etiology, diagnosed by upper endoscopy, 602 gastric polyposis and cecal polyp as cause of, 391 MALT lymphoma of colon and, 387 ribavirin-induced, recombinant human erythropoietin role in management, 315 Angioedema, isolated visceral, ACE-inhibitor-induced, as cause of abdominal pain, 656 Angiogenesis, vascular endothelial growth factor upregulation by cyclooxygenase-2 role in promotion of, in colorectal carcinoma, 340 Angiopoietin, expression in gastric cancer, 125 Angiosarcoma, presenting as acute liver failure, 654 Anisakiasis, of colon, presenting as bowel obstruction, 477 Antiemetic medications, long-term efficacy of, 867 Antireflux surgery, laparoscopic gastroesophageal junction motility and function after, 22 preoperative evaluation impact on, 46 Apheresis granulocyte adsorption, as adjunct to conventional therapy in corticosteroid-dependent ulcerative colitis, 781 granulocyte/monocyte, in ulcerative colitis, 774 Appendagitis, epiploic, as cause of abdominal pain, 549 Appendicitis adult-onset, colonoscopy in evaluation in postoperative period, 472 chronic, presenting as Crohn’s disease, 423 as complication of colonoscopy, 644 Argon plasma coagulation, ablation of Barrett’s esophagus, comparison with multipolar electrocautery, 98 Arthritis, sulfasalazine treatment for, as cause of eosinophilic colitis, 553 Ascites eosinophilic, eosinophilic gastroenteritis presenting as, 406 hepatic hydrothorax with, management, 552 new-onset, Waldenstrom’s macroglobulinemia presenting as, 524 pancreatic, presentation in infant, 580 spontaneous bacterial peritonitis and, incidence, characteristics, and outcomes, 292 Aspergillus, gastric ulcer and bleeding and, 402 Aspirin, rofecoxib or naproxen and, gastrointestinal tolerability of, in osteoarthritis, 717 Asthma, gastroesophageal reflux and, medical vs. surgical treatment of reflux in, 703 Atopy, ringed esophagus and, 27 Autoimmune disease, systemic, celiac disease and, 415 Autoimmune overlap syndrome, treatment options for, 306 Autonomic function testing, gastrointestinal motility disorder therapy ef-

AJG – September, 2002

fects, 174 Azathioprine, pulmonary nodules associated with, in Crohn’s disease, 690 Bacteria, esophageal, in Barrett’s esophagus, 42 Bacterial infection, hemodialysis-dependent hepatitis C patients, after interferon alpha treatment, 495 Barostat balloon distention, esophagus sensation and pain threshold determination, 73 symptoms produced by, 72 Barrett’s esophagus ablation, multipolar electrocautery vs. argon plasma coagulation, 98 after esophagectomy, 473 esophageal bacteria in, 42 esophageal dysmotility in, photodynamic therapy effects on, 70 esophageal pH normalization and relation to Barrett’s length and hiatal hernia, 111 fundic gland polyps and, 167 gastric antral metaplasia association with, 129 Helicobacter pylori infection and, 100 intestinal metaplasia prevalence in, 38 isolated segment complicating lye stricture, 527 long-segment decline in frequency of, 18 genomic analysis study, 24 long-term follow-up study, 116 low-grade dysplasia in, esomeprazole reversal of, 667 p27 expression in association with adenocarcinoma, 12 polypoid, case report and management, 476 PPI effects on esophageal acid and bile exposure in, 66 prevalence in family members, 109 primary care provider perceptions of, 707 quality of care in, outcomes study, 49 screening efficacy in gastroesophageal reflux, 33 screening in upper endoscopy patients, cost-effectiveness, 741 short-segment, long-term follow-up study, 116 surveillance endoscopy of, ACG practice guidelines impact on, 926 surveillance impact on survival, 83 telomerase and photodynamic therapy for, 104 ursodeoxycholic acid effects on inflammation and PGE2 production, 53 Barrett’s metaplasia p27 expression in, association with adenocarcinoma, 12 PPI effects on carcinoma/dysplasia incidence, 6 Bell’s palsy, as complication of interferon therapy for hepatitis C, 634 Benzocaine, topical, methemoglobinemia after, 664 Benzodiazepine, hiccups induced by, as predictor of GERD, 101 Bile duct stones, endoscopic stomata of stone migration as predictor of, 183 Bile ductopenia, adult idiopathic, 409 Bile exposure, in Barrett’s esophagus, PPI effects on, 66 Bile lithogenicity, alterations, postmenopausal women on hormone replacement therapy, 180 Biliary cirrhosis characteristics and presentation in men, 296 presentation in hepatology practice, 295 Biliary cyst adenoma, extrahepatic, case report, 616 Biliary disease, ERCP and EUS for evaluation of, 211 Biliary dyskinesia, cholecystectomy in, predictors of response in, 191 Biliary endoprosthesis, bioabsorbable self-expanding, long-term evaluation, porcine model, 200 Biliary epithelium, differentiation from cholangiocarcinoma, ERCP role, 225 Biliary obstruction malignant, Wilson-Cook Za stent for palliation of, evaluation study, 188 refractory celiac disease of ampulla of Vater as cause of, 431 Biliary papillomatosis, intraductal photodynamic therapy management, 625 Biliary sphincterotomy, hemoclips for bleeding control in, 649 Biliary stenting, cryosurgical/radiofrequency ablation and, in metastatic liver disease, 202 Biliary tract, malignancy cholangiocarcinoma associated with Clonorchis sinensis infection, 461 pancreatic divisum and, 208

Subject Index to Abstracts

S323

Bilirubin, delayed rise in, ischemic hepatopathy and, case series and literature review, 281 Bloating, EGG and water load test for differentiation from nausea, 128 Blood donors, hepatitis C prevalence in, 291 Blue nail syndrome, FD&C blue dye 1 and, 378 Bone mineral density, budesonide vs. prednisolone effects on, in ileocecal Crohn’s disease, 827 Bone synthesis markers, in Crohn’s disease, infliximab association with, 819 Bouveret’s syndrome, holmium laser lithotripsy management of, case report, 441 Bowel, irritable: see Irritable bowel syndrome Bowel composite score, in irritable bowel syndrome, validation of, 839 Bowel disease, inflammatory: see Inflammatory bowel disease Bowel disorder, functional, prevalence and risk factors, population-based study, 860 Bowel obstruction anisakiasis of colon presenting as, 477 endometriosis as etiology of, 617 Brain abscess, in diverticulitis, 521 Breast cancer colorectal neoplasia prevalence in, 347 metastatic, presenting as GI bleed in male, 660 Brunner’s gland hamartoma, endoscopic resection of, EUS role, 509 Budd-Chiari syndrome in antiphospholipid syndrome, mesoatrial shunt management in, 609 fulminant, secondary to adrenal carcinoma, 379 in patient with HIV and colon cancer, 416 Budesonide capsules, study after exposure to applesauce, 791 in Crohn’s disease, comparison with methylprednisolone, 799 Bullet, migrating, obstructive jaundice caused by, 630 Bullous pemphigoid, ulcerative colitis and, case report, 688 C1 esterase deficiency, presenting as intermittent abdominal pain, 650 CA19 –9 reliability as marker of pancreatobiliary malignancy, 487 traumatic abdominal pain and, pancreatic adenocarcinoma diagnosis and, 568 Cancer: see specific type or site Cancer surveillance, Barrett’s esophagus and, effects on survival, 83 Carcinoma, PPI therapy effects on incidence in Barrett’s metaplasia, 6 Cardiovascular prophylaxis, Helicobacter pylori eradication before, 170 Carnitine, deficiency of, in hyperemesis gravidarum receiving total parental nutrition, 408 Caroli’s disease, autoimmune hepatitis and, case report, 605 Cat scratch disease, incidence and case report, 576 Catatonia, after liver transplantation, electroconvulsive therapy for, adolescent, 433 Cecal polyps, gastric polyposis and, as cause of iron deficiency anemia, 391 Cecostomy, percutaneous endoscopic, recurrent Ogilvie’s syndrome, 531 Celecoxib, GI safety, comparison with NSAID, 135 Celiac artery, thrombosis, manifesting as acute gangrenous cholecystitis, 618 Celiac disease diagnosis after Whipple’s pancreaticoduodenectomy, 457 duodenal adenoma as complication of, 393 hepatitis B vaccine nonresponse and, 232 immunosuppressive therapy in renal transplant patient role in remission of, 597 presenting as immunoproliferative small intestinal disease, 401 primary hyperparathyroidism and, 440 primary sclerosing cholangitis and, case report and literature review, 258 refractory, of ampulla of Vater, as cause of papillary stenosis and biliary obstruction, 431 systemic autoimmune disorders associated wtih, 415 Celiac sprue, screening in first-degree relatives of patients, 239 Cerulein, acute pancreatitis induced by, vitamin C/E supplementation abrogation of, 197 Cervical cancer, metastatic to small bowel, as cause of obscure gastroin-

S324

Subject Index to Abstracts

testinal bleeding, 429 Cervical spinal injury, achalasia after, 503 Chemokine response, mucosal, in ulcerative colitis, 755 Chemotherapy, postoperative, enteral wall stent for obstructing rectal cancer, 653 Chest pain noncardiac, esophageal acid exposure and motor events in, 64 theophylline effects on, 14 of undetermined origin, provocative tests in esophageal evaluation, 19 Children acute pancreatitis after hematopoietic stem cell transplantation, 184 Crohn’s disease, early diagnosis by capsule endoscopy, 235 cystic fibrosis, esophagitis in, 3 pancreatic ascites, presentation in infant, 580 white specks in esophageal mucosa as indicator of eosinophilic esophagitis, 93 Cholangiocarcinoma Clonorchis sinensis, biliary tract malignancy and, 461 differentiation from benign biliary epithelium, ERCP role, 225 EUS for evaluation of, 871 EUS-guided fine-needle aspiration for diagnosis of, 212 Cholangiography, clonorchiasis identified on, 547 Cholangitis autoimmune, manifesting as cutaneous lymphocytic vasculitis of lower extremities, 273 hepatic B cell lymphoma presenting as, 683 primary sclerosing celiac disease and, case report and literature review, 258 clinical spectrum, 313 infliximab effects on liver function test in, 213 liver transplantation for, cholangiocarcinoma in remnant duct after, 619 as presentation of Job’s syndrome, 459 presenting as acute pancreatitis, 482 Cholecystectomy biliary dyskinesia, predictors of response in, 191 percutaneous, in acute cholecystitis, 205 Cholecystitis acute, percutaneous cholecystectomy in, 205 acute gangrenous, celiac artery thrombosis manifesting as, 618 gallbladder perforations in, case reports, 201 Cholecystoduodenal fistula, Mirizzi’s syndrome and pancreatitis evolving into, 601 Cholecystokinin deficiency, malabsorption due to, treatment in boy with autoimmune polyglandular syndrome, 413 in fibrotic ampulla, 426 Choledochal cysts, diagnosis in adults, 229 Choledocholithiasis, asymptomatic, prevalence in elderly patients, 209 Cholestasis, sulfasalazine-induced ductopenic, in ulcerative colitis, 517 Cholesterol, as indicator of liver compromise in amyloidosis, 284 Cholesterol crystal embolization, gastric ischemia from, case report, 639 Cholesterol ester storage disease, liver transplantation effects, 522 Chromoendoscopy colorectal neoplasia detection, in ulcerative colitis, 767 with indigocarmine, colorectal adenoma detection, 884 Cimetidine, continuous, gastric pH control in ICU patients, comparison with intermittent IV pantoprazole, 143 Cirrhosis: see also Biliary cirrhosis; Liver cirrhosis alcoholic, splenic rupture after resuscitation for bleeding events in, 673 bacterial infection, alcohol intake effects on, 224 hepatitis A virus antibody prevalence in, 271 hepatitis C prevalence in, 291 nodular antral gastropathy in, 446 secondary to hepatitis C, variceal bleeding in, 303 Clobenzorex, hepatitis induced by, case report from Mexico border, 624 Clonorchiasis, identification by cholangiography, 547 Clostridium difficile, infection, after total colectomy, 483 Coccidioidomycosis, pulmonary, infliximab as cause of, 475 Coccygodynia, causes of, 525

AJG – Vol. 97, No. 9, 2002

Coherin peptides response and remission in Crohn’s disease, 763 response and remission in ulcerative colitis, 765 2-year remission in Crohn’s disease, 764 Colectomy gastric electrical stimulation and, 362 total, Clostridium difficile infection after, 483 Colitis cocaine, comparison with chronic ulcerative colitis, case report and literature review, 445 collagenous community-based practice experience, 364 linear colonic ulcers and, in patient taking Cox-2 NSAID, 385 treatment interventions for, 756 Clostridium difficile, in surgical patients, incidence and risk factors, 355 eosinophilic, sulfasalazine treatment for arthritis as cause, 553 glutaraldehyde-induced, mimicking ischemic colitis, 438 herpes simplex, immunocompetent patient with ulcerative colitis, 555 ischemic glutaraldehyde-induced colitis presenting as, 438 incidence of, 368 microscopic in diverticular disease, 342 NSAID use association with, 775 MRSA-associated, presentation and etiology, 606 severe, in pregnancy, management and outcome, 824 ulcerative: see Ulcerative colitis Colon adenocarcinoma, invasive, erythroderma as manifestation of, 558 anisakiasis of, presenting as bowel obstruction, 477 cancer in HIV patient, Budd-Chiari syndrome in, 416 PACAP and PAC1 expression in, 360 prostaglandin expression as indicator of growth and invasiveness, 345 sigmoid, presenting as perianal mass due to sigmoidoanal intussusception, 665 cancer screening, patient compliance with, easy access for colonoscopy effects, 329 crypts, three-dimensional computerized modeling of, 370 diverticulum, giant, case report, 572 interstitial cells of Cajal distribution in, in slow-transit constipation, 359 ischemia, irritable bowel syndrome and, medical care patterns in, 850 lesion detection, bowel preparation quality predictors and impact on, in colonoscopy, 732 linear ulcers, collagenous colitis and, in patient taking Cox-2 NSAID, 385 lymphangiomas of, case reports, 523 lymphoma, presenting as diminutive colonic polyp, 519 MALT lymphoma of, presenting with iron deficiency anemia, 387 obstruction, impacted giant calcified fecolith as cause of, 669 polypoid mass, cytomegalovirus presenting as, 485 polyps colonic lymphoma presenting as, 519 diverticulosis and, association between, 336 large, office-based polypectomy safety and efficacy, 917 risks in erosive esophagitis, 349 sporadic adenomatous, polyamines and ornithine decarboxylase role in, 344 Strongyloides stercoralis presenting as, 621 primary lymphoma of, case reports, 479 stricture and perforation, after hemolytic-uremic syndrome, children, 675 tuberculosis, in HIV, 371 tumor cells, PACAP and PAC1 expression in, 360 varices, as presentation of mesenteric vein thrombosis, 463 Colonic bowel wall thickening, colonoscopy role in evaluation, 374 Colonography, CT, extracolonic findings prevalence and impact in, 339 Colonoscopy adult-onset appendicitis evaluation, 472 appendicitis as complication of, 644

AJG – September, 2002

assessment of patient experience with, 351 bowel preparation kit vs. customary preparation for, 348 bowel preparation quality predictors and impact on colonic lesion detection, 732 colonic bowel wall thickening evaluation, 374 colorectal carcinoma screening, comparison with flexible sigmoidoscopy, 373 easy access for, colon cancer screening compliance and, 329 endoscopic hemorrhoidal band ligation at time of, 939 esophagogastroduodenoscopy and, procedure-related adverse events, 740 lavage preparations, patient preferences in, 887 L-glucose as colon cleansing agent before, 869 mortality and, after colorectal carcinoma, 723 neoplasia detection, gender/age implications, 346 outpatient, preparation comparison study, 327 preparation adequacy, hydrogen breath test with/without fiber for evaluation of, 335 pulsed irrigation evacuation preparation for, 908 right colonic ischemia as complication of, 636 screening asymptomatic Crohn’s disease detection by, 809 in elderly patients, 361 screening benefits in asymptomatic individuals, 376 screening vs. nonscreening, racial disparity in compliance, 701 terminal ileum intubation during, diagnostic value of, 897 TIBC as predictor of negative outcome, 888 virtual, multicenter study, 369 wide-angle, impact on miss rate and efficiency, 353 Colorectum adenomas, detection by chromoendoscopy with indigocarmine, 884 cancer mortality and follow-up colonoscopy after, 723 NSAID use and prevention of, 710 stool DNA analysis for detection and follow-up of, 332 type 2 diabetes mellitus and risk of, 367 vascular endothelial growth factor upregulation by cyclooxygenase-2 role in angiogenesis promotion in, 340 cancer screening benefits in asymptomatic individuals, 376 colonoscopy vs. flexible sigmoidoscopy, 373 elderly patients, 363 long-term follow-up of program for, 354 obstacles as perceived by physicians, 372 optimal age in females, 334 patient awareness of, 333 race impact on, 341 screening implications polyps and tumor location, 744 standard vs. ultraflexible sigmoidoscopy for, 935 test utilization in Medicare population, 343 trends on urban primary care setting, 330 cancer staging, colonoscopic lymphatic mapping effects on, 927 malignancy, self-expandable metal stents role in, 874 neoplasia, prevalence in breast cancer patients, 347 neoplastic, virtual colonoscopy for detection of, multicenter study, 369 polyps, smoking as predictor of, 350 Clostridium difficile, colitis, in surgical patients, incidence and risk factors, 355 Common bile duct dilation, asymptomatic, in chronic methadone patients, 219 strictures, in chronic pancreatitis, endoscopic management of, 217 Complementary and alternative medicine gastroenterologist knowledge, use, and assessment of, 728 inflammatory bowel disease and, 784 instrumental music, stress reduction during gastroscopy and, 893 meditation, stress reduction in gastroscopy and, 892 Computed tomography abdominal, acute pancreatitis evaluation, 182 abdominal pain, primary care outpatients, 715 Constipation

Subject Index to Abstracts

S325

chronic fasting breath hydrogen correlation with severity, 323 orocecal time in, 226 functional, irritable bowel syndrome and, symptomatic differentiation, 856 slow-transit, interstitial cells of Cajal distribution in colon in, 359 Contraceptives, oral, women with irritable bowel syndrome, 866 Cope’s syndrome, case report and review, 395 Corpus inflammation, Helicobacter pylori-induced, PPI therapy mechanisms, 151 Corynebacterium jeikeium, sepsis induced by, Ogilvie’s syndrome and, in leukemic patient, 511 Crohn’s disease anti-Saccharomyces cerevisiae antibodies in feces as indicator of, 771 asymptomatic, detection by screening colonoscopy, 809 azathioprine-associated pulmonary nodules in, 690 bone synthesis markers in, infliximab association with, 819 budesonide vs. methylprednisolone effects, 799 capsule endoscopy for evaluation of, 913 chronic appendicitis presenting as, 423 Coherin peptides effects on response and remission in, 763 Coherin peptides effects on 2-year remission, 764 early diagnosis by capsule endoscopy, children, 235 enterovaginal fistula in, case reports, 666 familial, NOD2 gene in, clinical manifestations in, 794 familial vs. sporadic, Vienna classification of characteristics, 782 fistulizing disability and unemployment in patients with, 803 infliximab effects on hospitalization and surgical procedures, 805 fistulous, infliximab maintenance therapy in, 786 fracture risk and, thyroid disease role, 757 gastric, infliximab efficacy, 581 gastric outlet obstruction as complication in, 534 gastroduodenal, immunomodulator therapy effects, 829 granulomatous, esophageal, case report, 661 hepatic abscess as initial manifestation of, 518 ileoanal pouches and, limb ulcerations as predictor of, 821 ileocecal, budesonide vs. prednisolone effects on bone mineral density in, 827 ileocolic resection for, 6-mercaptopurine efficacy in prevention of anastomotic site recurrence after, 778 infliximab association with risk of intestinal strictures/obstruction, 776 effects on extraintestinal manifestations of, 808 effects on gelatinase B and tenascin in mucosa, 788 maintenance therapy correlation with clinical response, 792 stricture response to, 777 therapy effects, clinical experience, 798 intestinal tuberculosis presenting as, 399 ischemic necrosis of bilateral tibia and fibula in, 469 ISIS 2302 safety and pharmacokinetic study, 761 6-mercaptopurine and azathioprine dose response and metabolism in lymphoblast cell line, 806 mercaptopurine-induced leukopenia in, granulocyte colony-stimulating factor role in, 579 mycobacterial infection and, skin testing for evaluation of association between, 813 mycobacterial infection mimicking erythema nodosum, infliximab therapy and, 800 NOD2 mutation in relatives of patients with, inflammatory bowel disease and, 754 pancreatitis risks and, 689 perianal, examination under anesthesia, effects in Remicade complications, 817 preoperative surgical outcome in patients receiving concomitant immunomodulator therapy, 795 pneumoencephalomeningitis and, 492 posterior reversible leukoencephalopathic syndrome and, 474 quality of life after surgery for, 762 relapse in, clinical and biological predictors in, 823

S326

Subject Index to Abstracts

remission effects on hospitalization and surgery, 789 leukopenia with fever due to mercaptopurine induction of, 790 secondary amyloidosis of liver as primary manifestation of, 488 tumor necrosis factor-a´ and receptor genotype/phenotype associations in, 758 vertebral fractures prevalence in, 828 vulvular, case report and literature review, 542 Cryptosporidiosis, of GI tract, pneumatosis coli and, AIDS patients, 513 Crypts, colonic, three-dimensional computerized modeling of, 370 CT: see Computed tomography Cyclooxygenase gastric, NSAID inhibition of, comparison study, 172 regulation, after nitric oxide synthase inhibition in portal hypertension, 310 Cystic fibrosis chronic pancreatitis as manifestation of, 588 esophagitis and, 3 intestinal polyps incidence in, 326 liver disease progression in adults with, 255 Cysts bronchogenic, below diaphragm, as cause of nonulcer dyspepsia, 574 choledochal: see Choledochal cysts Cytochrome P450 2R1, genetic polymorphism, susceptibility to antituberculosis drug-induced hepatitis and, 267 Cytology, interpretation of results, in EUS-guided fine-needle aspiration, 221 Cytomegalovirus, presenting as polypoid colonic mass, 485 Cytomegalovirus infection, in steroid-refractory ulcerative colitis, 783 Demographics of gastroparesis, 157 racial, rabeprazole-based triple therapy effects on Helicobacter pylori eradication and, 50 Diabetes mellitus gastrointestinal symptoms in, 845 gastroparesis, symptoms and outcome comparison with idiopathic gastroparesis, 156 hemodialysis patients, gastroparesis in, correlation with glycemic control and hematocrit, 117 type 2, colorectal cancer risks and, 367 Diarrhea chronic collagenous colitis and, treatment interventions for, 756 in HIV, mesalamine vs. placebo for treatment, 357 intractable, abdominal pain and, in short bowel syndrome, octreotide long-acting release after, 456 liver abscess and, as initial manifestations of ulcerative colitis, 427 refractory, splenic lymphoma as cause of, octreotide and chemotherapy response, 663 Diet elemental, trypsin synthesis and turnover in acute pancreatitis, 223 high-fiber, paroxetine and, irritable bowel syndrome effects, 835 Dieulafoy’s lesion esophageal, endoscopic band ligation of, 539 surgical view of, 516 Digestive disease, health care workers definition and diagnosis, 237 Diverticular disease, microscopic colitis in, 342 Diverticulitis, brain abscess in, 521 Diverticulosis, colonic polyps and, association between, 336 Diverticulum giant colonic, case report, 572 giant sigmoid, case report, 637 DNA analysis, stool, detection and follow-up of colorectal carcinoma, 332 Doppler imaging, gray scale imaging and, prototype linea echoendoscope, 928 Drink testing, self-efficacy in, 831 Duodenoscope, ERCP assisted by, 222 Duodenum adenoma

AJG – Vol. 97, No. 9, 2002

as complication of celiac disease, 393 prevalence of, 230 diverticular hemostasis, endoclipping of bleeder and feeder, 425 hematochezia from, superior mesenteric vein coil embolization as cause of, 610 intraluminal pancreatic pseudocyst of, endoscopic therapy effects, 386 obstruction, pneumobilia and, intestinal strongyloidiasis presenting with, 645 sarcoma, presenting as pancreatic adenocarcinoma, 407 Dyspepsia functional, predictive value of symptoms in, 123 heartburn treatment and response predictors in, 107 in minority elderly patients, 118 nonulcer, bronchogenic cyst below diaphragm as cause of, 574 severity of, assessment in children, Helicobacter pylori infection and, 695 Dysphagia aging and, 8 meal-induced, otalgia and, secondary to pyriform sinus fistula, 575 nonobstructive, esophageal manometry in, 113 oropharyngeal, intraluminal impedence and esophageal manometry for evaluation, 28 post fundoplication, preoperative esophageal sphincter pressure as predictor of, 67 Dysplasia low-grade, in Barrett’s esophagus, esomeprazole reversal of, 667 p27 expression in, association with adenocarcinoma, 12 PPI therapy effects on incidence in Barrett’s metaplasia, 6 Ectasia, gastric antral vascular, review and evaluation of, 162 EGD: see Esophagoduodenostomy EGG: see Electrogastrography Elderly patients asymptomatic choledocholithiasis prevalence in, 209 colonoscopy screening in, 361 colorectal cancer screening, 363 dyspepsia, minority population, 118 ERCP in, 550 gastroesophageal reflux disease patterns in, 54 percutaneous endoscopic gastrostomy tube placement in patients 90 years of age and older, 587 screening flexible sigmoidoscopy, physician vs. nonphysician performance success, 933 Electrical stimulation, gastric combination with colectomy, 362 for gastroparesis, health-related quality of life after, 171 gastroparesis effects, 145 gastroparesis symptom improvement and, 169 placement for gastroparesis, laparoscopy vs. laparotomy effects on outcome, 752 response in drug-refractory gastroparesis, 853 Electrocautery endoscopic snare, gastric duplication cyst management, 505 multipolar, ablation of Barrett’s esophagus, comparison with argon plasma coagulation, 98 needle knife, safety and efficacy in Schatzki’s ring, 92 Electroconvulsive therapy, catatonia after liver transplantation in adolescent and, 433 Electrogastrography gastric function assessment, 124 water load test and, bloating vs. nausea differentiation, 128 Electrolytes, patterns of, in long-term total parenteral nutrition, 481 ELISA: see Enzyme-linked immunosorbent assay Embolism, portal venous gas, sigmoidoscopy-induced, 449 Embolization, gastric artery, ablation, bleeding stromal tumor of stomach, 471 Empyema, spontaneous bacterial peritonitis and, Pasteurella mutocida as cause of, in cirrhosis, 604 Encephalopathy, hepatic, congenital intrahepatic shunt as cause of, case report and literature review, 420

AJG – September, 2002

Endoclipping, of bleeder and feeder, in duodenal diverticular hemostasis, 425 Endoclips, as anchors for metal stents, 430 Endometriosis, as etiology of bowel obstruction, 617 Endoscopic activity index, treatment choice and therapeutic effect evaluation in ulcerative colitis, 822 Endoscopic retrograde cholangiopancreatography anastomotic strictures after liver transplantation, 282 asymptomatic common bile duct dilation in methadone patients, 219 cholangiocarcinoma differentiation from benign biliary epithelium, 225 duodenoscope-assisted without fluoroscopy, 222 elderly patients, 550 EUS and, in pancreatic and biliary disease, 211 pancreatitis, allopurinol role in prevention, 921 pancreatitis after lidocaine spray on ampulla of Vater effects on incidence of, 190 volume expansion for prevention of, 187 Endoscopic ultrasound cholangiocarcinoma evaluation, 871 endoscopic resection of Brunner’s gland hamartoma, 509 ERCP and, in pancreatic and biliary disease, 211 esophageal cancer staging, accuracy of, 900 fine-needle aspiration guided by cholangiocarcinoma diagnosis utility, 212 cytology results interpretation, 221 evaluation of mediastinal/periintestinal lymph nodes, 914 extraluminal malignancy diagnosis and, 903 liver mass in advanced liver disease and, comparison with true-cut biopsy, 305 pancreatic cancer, diagnostic accuracy and complication assessment, 196 hemosuccus pancreaticus diagnosis, 583 locoregional staging of esophageal cancer, 906 needle drainage guided by, pancreatic pseudocysts, 214 pancreatic acinar cell carcinoma detection, 567 rectal adenocarcinoma prediction after preoperativge brachytherapy, 919 sclerosing autoimmune pancreatitis, 506 ulcerative colitis management and, 760 Endoscopy Barrett’s esophagus prevalence in family members, 109 bile duct strictures in chronic pancreatitis, 217 Bouveret’s syndrome, holmium laser lithotripsy for management, 441 cap-assisted, localization of arterial bleeder in sliding hiatal hernia, 428 capsule clinical utility of, 912 complications and problems encountered, 916 Crohn’s disease evaluation, 913 early diagnosis of Crohn’s disease, children, 235 efficacy in diagnosis and treatment options, 248 endoscopy nurse assessment accuracy, 902 gastrointestinal bleeding diagnosis and, 243 performed by nonendoscopists, 247 small bowel varices diagnosis, 234 small intestinal varix detection, 918 gastrointestinal, propofol sedation, recovery times and safety, comparison with conscious sedation, 911 gastrointestinal appearance of Sweet’s syndrome, 489 gastrointestinal procedures, propofol vs. meperidine and midazolam for, safety and efficacy study, 753 GI clinic referred, patient anxiety and procedure tolerance, 872 intraluminal pancreatic pseudocyst of duodenum resolution by, 386 M2A capsule, vascular stricture localization, 390 patient concerns regarding procedures, 749 patient difficulty and satisfaction, predictors of, 747 patient recall of, written reports effects on, 886 resection of gangliocytic paraganglioma involving ampulla of Vater, 593 Schatzki’s ring and, 52 stone migration, as predictor of bile duct stones, 183 surveillance, Barrett’s esophagus, ACG practice guidelines impact on, 926

Subject Index to Abstracts

S327

unplanned events in unit for, 889 unsedated, patient characteristics, 885 upper Barrett’s esophagus screening in, cost-effectiveness, 741 esophageal cancer diagnosis and, 112 iron deficiency anemia diagnosed by, 602 upper gastrointestinal, general practitioner indications for, appropriateness of, 881 video capsule obscure gastrointestinal bleeding evaluation, 249 recording time in, 934 small intestinal lesion detection, comparison with small bowel followthrough and abdominopelvic CT, 244 wireless capsule inflammatory bowel disease evaluation, comparison with ileoscopy and small bowel follow-through, 802 obscure gastrointestinal bleeding detection, comparison with push enteroscopy, 252 small bowel pathology assessment, 920 small bowel ulcer detection in normal enteroclysis, 242 surgical intervention and, 907 Endotoxemia, liver damage in alcoholic liver disease and, 277 Enteritis, idiopathic nongranulomatous, villous atrophy, Crohn’s disease and, 561 Enterochromaffin-like cells, gastric, gastric acid secretion role, 163 Enteroscopy, push, obscure gastrointestinal bleeding, comparison with wireless capsule endoscopy, 252 Enterovaginal fistula, in Crohn’s disease, case reports, 666 Enteryx, gastroesophageal reflux disease efficacy, 37 Enzyme-linked immunosorbent assay, Helicobacter pylori detection, proteinuria effects on, 147 Epidemiology asymptomatic choledocholithiasis, prevalence in elderly patients, 209 Barrett’s esophagus prevalence in family members, 109 gastroesophageal reflux disease, health care seeking behavior in Pakistan, 32 Helicobacter pylori prevalence in a community hospital, 154 Helicobacter pylori-negative peptic ulcer disease incidence, 166 irritable bowel syndrome in employed U.S. population, 737 health care utilization and medical use in U.S., 855 prevalence and impact in the U.S., 854 ischemic colitis, incidence of, 368 Episcleritis, Crohn’s disease and, infliximab treatment, 458 Epithelial neoplasms, of gastrointestinal tract, upregulation of KChAP/ PIAS3B expression in, 150 ERCP: see Endoscopic retrograde cholangiopancreatography Erythroderma, as manifestation of invasive adenocarcinoma of colon, 558 Erythropoietin, recombinant human, role in management of ribavirin-induced anemia, 315 Esomeprazole administration through nasogastric/gastrostomy tubes, 9 age correlation with effectiveness, in esophagitis, 43 delivery through nasogastric and gastrostomy tubes, 55 erosive esophagitis symptom duration impact on severity and, 58 gastroesophageal reflux disease and, comparison with pantoprazole, 60 intragastric pH effects, 61 low-grade dysplasia in Barrett’s esophagus and, 667 nasogastric tube vs. oral administration, 69 pellets, stability in beverages, 59 sleep disturbance in erosive esophagitis and, 95 Esophageal body, contractions in, nutcracker esophagus and, 86 Esophageal disease, pH monitoring and esophageal manometry clinical utility, 68 Esophageal dysmotility, in Barrett’s esophagus, photodynamic therapy effects, 70 Esophageal manometry, intraluminal impedence and, oropharyngeal dysphagia evaluation, 28 Esophageal motility GERD management of Stretta procedure and, 85

S328

Subject Index to Abstracts

heartburn and, 115 reflux in nonerosive reflux disease, 84 wet swallows during manometry as sample of, 5 Esophageal mucosa, white specks in, as indicator of eosinophilic esophagitis, children, 93 Esophageal ring, pseudodiverticulum and, complicated by food bolus impaction, 394 Esophageal spasm, diffuse, distal esophagus evaluation and, 31 Esophageal sphincter, lower function of, gastric pacer activation in obese GERD patients, 78 preoperative pressure, as predictor of post fundoplication dysphagia, 67 sildenafil effects on, 102 Esophageal varices, noninvasive pressure measurement via balloon method, 309 Esophagectomy, Barrett’s esophagus after, 473 Esophagitis age impact on severity and esomeprazole/lansoprazole treatment, 43 cystic fibrosis and, 3 drug-induced eosinophilic, case report, 585 eosinophilic etiology and case report, 658 presentation of, 526 white specks in esophageal mucosa as indicator of, children, 93 erosive colon polyp risk in, 349 rabeprazole safety and tolerability in, 106 sleep disturbance in, esomeprazole effects, 95 symptom duration impact on severity, 58 symptom resolution predictors, 105 reflux, salivary glycoconjugate secretion in, 81 severity of, GERD symptom duration and, 57 ulcerative, esophageal sparing in, as indicator of autoimmune disorder, 659 Esophagoduodenoscopy during push enteroscopy, missed lesions in, rate of, 894 unsedated ultrathin, acceptability in patients, 931 Esophagogastroduodenoscopy, colonoscopy and, procedure-related adverse events, 740 Esophagoscopy, unsedated, transnasal and transoral routes, comparison with conventional endoscopy with sedation, 895 Esophagus acid exposure abnormality in GERD, 1 erosive GERD and, 65 evening vs. morning rabeprazole administration effects on control of, 10 heartburn and, 115 motor events and, in noncardiac chest pain, 64 pH monitoring for assessment of, 29 rabeprazole vs. omeprazole effects on, in GERD, 74 adenocarcinoma, polypoid Barrett’s esophagus and, 476 adenocarcinoma of, intestinal metaplasia and, international prevalence study, 7 bacteria, in Barrett’s esophagus, 42 Barostat balloon distention of, sensation and pain threshold determination, 73 Barrett’s: see Barrett’s esophagus cancer EUS for locoregional staging, 906 EUS staging accuracy, 900 salvage photodynamic therapy after radiation therapy, 51 upper endoscopy sensitivity in diagnosis, 112 upper endoscopy sensitivity in diagnosis of, 112 Dieulafoy’s lesion, endoscopic band ligation of, 539 evaluation of, chest pain of undetermined origin and, 19 food impaction, long-term follow-up study, 880 function of, aging effects on, 8 functional chest pain and, theophylline effects on, 14 intramural pseudodiverticulosis of, 424 linitis plastica of, case report, 442

AJG – Vol. 97, No. 9, 2002

nutcracker contractions in the middle esophageal body, 86 psychopathology associated with, 99 ringed, GERD or atopy association with, 27 squamous papillomatosis of, 643 symptoms produced by barostat balloon distention, 72 videofluoroscopy, quantitative reporting scale development, 94 warfarin-induced necrosis, 676 Ethnicity/racial considerations chronic atrophic gastritis, Japanese Americans vs. native Japanese, 146 colorectal cancer screening, race impact on, 341 inflammatory bowel disease, 768 TNF genotypes, ASCA positivity, and phenotypes in, Hispanic patients, 812 rabeprazole-based triple therapy effects on Helicobacter pylori eradication and, 50 racial differences in hemoglobin and neutrophil levels in interferon/ ribavirin therapy for hepatitis C, 285 racial differences in neutrophil count in PEG-interferon/ribavirin treatment in hepatitis C, 280 screening vs. nonscreening colonoscopy, 701 upper gastrointestinal disorders and, minority veterans, 17 Etiology dyspepsia, in minority elderly patients, 118 of gastroparesis, 157 portal vein thrombosis, five-year cohort study, 294 splenic vein thrombosis, five-year cohort study, 294 EUS: see Endoscopic ultrasound Failure to thrive, lipase deficiency and, 648 Familial adenomatous polyposis, acute pancreatitis as complication of, 594 Familial studies Barrett’s esophagus prevalence in family members, 109 celiac sprue, screening in first-degree relatives of patients, 239 exocrine pancreatic insufficiency and muscular dystrophy, in father and daughter, 403 Fecal incontinence evaluation by questionnaire vs. endoanal ultrasound-demonstrated defects, 882 physician knowledge and addressing of, 849 Feces, anti-Saccharomyces cerevisiae antibodies in, as indicator of Crohn’s disease, 771 Fecolith, giant calcified, impaction, as cause of colonic obstruction, 669 Fentanyl, cardiopulmonary complications of, comparison with meperidine, 923 Fibrosis hepatic, hepatitis C and, interferon effects on, 283 mediastinal, in inflammatory bowel disease, 687 retroperitoneal, progesterone efficacy, 562 Fistula enterocutaneous, expandable metal stent for management, 554 gastrocolic, case report and literature review, 398 pancreaticopleural, as cause of pleural effusion, 400 pouch vaginal, closure with infliximab, 528 pyriform sinus, meal-induced dysphagia and otalgia secondary to, 575 Food allergy, villous atrophy and, after liver transplantation with tacrolimus immunosuppression, children, 262 Food bolus impaction, esophageal ring and pseudodiverticulum complicated by, 394 Food coloring, FD&C blue dye 1 and blue nail syndrome, 378 Food impaction, esophageal, long-term follow-up study, 880 Fracture risk, Crohn’s disease and, thyroid disease role, 757 Fructose intolerance, in irritable bowel syndrome, 833 Fructose tolerance testing, in gastrointestinal disorders, 837 Fundic gland, polyps, treatment and outcome at university medical center, 138 Fundoplication, failed surgical, as indicator for endoluminal gastroplication, 646 Fusobacterium necrophorum sepsis, presenting as liver failure, 577 Gallbladder

AJG – September, 2002

dysfunction of, eosinophilic gastroenteritis associated with, 207 emptying, alterations, postmenopausal women on hormone replacement therapy, 180 emptying impairment, cholecystectomy for, gastric emptying preoperative assessment influence on outcome, 206 perforations of, case reports, 201 Garlic, Helicobacter pylori eradication effects, 161 Gastrectomy, acid-reducing medication use after, 722 Gastric abscess, intramural, case report, 631 Gastric acid evening vs. morning rabeprazole administration effects on control of, 10 gastrin role in regulation of, 79 postprandial, in GERD, 2 secretion oral vs. intravenous lansoprazole for suppression, 155 pentagastrin-stimulated, pantoprazole inhibition of, 148 secretion of age/gender influence on, 119 enterochromaffin-like cells role in, 163 Gastric antrum, ectasia, review and evaluation of, 162 Gastric bypass, Roux-en-Y, anastomotic stricture development after, 164 Gastric cancer angiopoietin expression in, 125 chronic atrophic gastritis, Japanese Americans vs. native Japanese, 146 endoscopic mucosal resection, outcome study, 134 Helicobacter pylori treatment in family members, 177 pepsinogen screening, 139 pepsinogen screening efficacy, 137 Gastric duplication cyst, endoscopic snare electrocautery treatment, 505 Gastric electrical activity, measurement of, 175 Gastric emptying delayed, endoscopic pyloric balloon dilatation in, children, 877 as gastroparesis management predictor, 159 preoperative assessment, cholecystectomy for gallbladder emptying impairment, influence on outcome, 206 Gastric function, EGG for assessment of, comparison of systems, 124 Gastric ischemia, from cholesterol crystal embolization, case report, 639 Gastric outlet obstruction as complication in Crohn’s disease, 534 pedunculated hamartomatous gastric polyp and, 640 as presentation of Peutz-Jeghers syndrome, 465 Gastric pH control in ICU patients, pantoprazole effects, 141 intermittent IV pantoprazole vs. continuous cimetidine in ICU patients, 143 Gastric physiology, functional dyspepsia symptoms and, 123 Gastric polyps, pedunculated hamartomatous, gastric outlet obstruction and, 640 Gastric submucosal tumors fine needle aspiration biopsy utility in EUS evaluation of, 930 rendezvous laparoscopic endoscopy for resection after FNA diagnosis, 938 Gastric ulcer, Aspergillus and, outcome, 402 Gastric varices bleed, due to wandering spleen, 452 endoscopic band ligation of, 120 fundal, retrograde transvenous obliteration for management, 160 Gastrin, salivary protective role, 79 Gastrinoma, Zollinger-Ellison phenotype in absence of, 419 Gastritis chronic atrophic, Japanese Americans vs. native Japanese, 146 collagenous, collagenous sprue, collagenous colitis, bacterial overgrowth syndrome and, 444 Gastroduodenal ulcer, prophylaxis, NSAID vs. low-dow aspirin therapy, 742 Gastroduodenum, in ulcerative colitis, 628 Gastroenteritis, eosinophilic gallbladder dysfunction and, 207 presenting as massive eosinophilic ascites, 406 Gastroenterologists

Subject Index to Abstracts

S329

complementary and alternative medicine knowledge, use, and assessment, 728 female vs. male, salary comparison, 746 guideline adherence in 24 hour pH monitoring and esophageal manometry, 56 liver biopsy methods in U.S., 318 Gastroesophageal reflux asthmatics with, medical vs. surgical treatment of reflux in, 703 Barrett’s esophagus screening efficacy in, 33 intraluminal impedance and pH monitoring for diagnosis, 404 Gastroesophageal reflux disease atypical presentation in pregnancy, 82 benzodiazepine-induced hiccups as predictor of, 101 celiac disease and, 415 contractility in, manometry assessment of dry swallows and, 88 endoluminal gastroplication, configuration technique comparison, 89 endoluminal gastroplication as treatment for, 34 endoscopy-negative, treatment response predictors in, 36 Enteryx effects in, 37 erosive esophageal acid exposure effects, 65 rabeprazole efficacy on regurgitation symptoms, 47 rabeprazole for relapse prevention, 110 erosive/ulcerative, rabeprazole safety and tolerability in, 106 esophageal acid exposure abnormality in, 1 evening vs. morning rabeprazole administration efficacy, 10 gastric pacer activation in, lower esophageal sphincter function in, 78 health care seeking behavior in Pakistan, 32 Helicobacter pylori and, prevalence in minority veterans, 17 medical vs. surgical management, acid reduction use, 730 nonerosive, proton pump inhibitor effects, 718 pantoprazole vs. esomeprazole effectiveness, 60 patterns in elderly patients, 54 pH monitoring and, as predictor of pharyngeal reflux, 90 postprandial gastric acid in, 2 proton pump inhibitors effects on symptom relief, 48 proximal, laryngopharyngeal sensory testing effects on laryngoscopy diagnostic yield, 35 rabeprazole effects on symptoms, 726 rabeprazole maintenance therapy effects on relapse, 114 rabeprazole vs. omeprazole effects on esophageal acid exposure, 74 refractory, endoluminal gastroplication effects, 96 ringed esophagus and, 27 sleep measures in, 80 Stretta procedure management of, esophageal motility as factor in, 85 symptom association with acid reflux, 45 symptom duration impact on esophagitis severity, 57 symptom resolution predictors, 105 symptoms questionnaire validity and reproducibility, 743 ulcerative, rabeprazole for relapse prevention, 110 Gastroesophageal junction, motility and function after laparoscopic antireflux surgery, 22 Gastrointestinal bleeding/hemorrhage Aspergillus and, 402 colonic and gastric metastases from Merkel cell carcinoma as cause of, 460 detection by capsule endoscopy, 243 duodenal lipoma as cause of, diagnosis and management, 397 from ileal polyp, 623 lower hypernephroma as cause of, 596 technetium 99m-labeled bleeding scan utility in evaluation, 366 metastatic breast cancer presenting as, in male patient, 660 NSAID use as risk for, 168 obscure case report, 453 cervical cancer metastatic to small bowel as cause of, 429 diagnostic utility of Given imaging system and enteroscopy, 910 small bowel radiography for detection of, 246 video capsule endoscopy evaluation of, 249

S330

Subject Index to Abstracts

wireless capsule endoscopy detection of, comparison with push enteroscopy, 252 pancreatic pseudoaneurysm penetrating in stomach and hemosuccus pancreaticus as cause of, 494 pseudoxanthoma elasticum as cause of, 478 small bowel perforation and, in Wegener’s granulomatosis, case report, 514 time to first endoscopy and length of stay, weekend vs. weekday admittance, 700 upper emergent transnasal gastroscopy evaluation and assessment role in, 901 intravenous proton pump inhibitors effects on hospital mortality in, 702 nasogastric aspirate as risk predictor of endoscopic lesions in, 905 optimal treatment methods for, 705 outcome after endoscopic therapy, native vs. nonnative Americans, 751 sarcoidosis of small bowel presenting as, 657 treatment costs, Canadian hospitals, 925 Gastrointestinal disorders fructose tolerance testing in, 837 functional, after hours telephone calls, physician vs. patient perceptions, 713 rumination syndrome, diagnosis and treatment challenges, 144 sleep disorders and, 13 Gastrointestinal luminal obstruction, enteral metal stent placement using biliary accessories in, 922 Gastrointestinal mesenchymal tumors, 432 Gastrointestinal mucosa, compartmentalized HIV-1 evolution and, 365 Gastrointestinal procedures, patient preference assessment, survey development for, 734 Gastrointestinal stromal tumors, mesenchymal tumor characterization, 432 Gastrointestinal symptoms in diabetes mellitus, 845 prevalence in amyotrophic lateral sclerosis, 862 Gastrointestinal tract eosinophilic infiltration of, patient profile, 766 epithelial neoplasms of, upregulation of KChAP/PIAS3B expression in, 150 immunomodulation by probiotic Lactobacillus reuteri, 229 incidental PET scan significance in, 250 lymphangiomas of, case reports, 523 malignancy, inoperable, self-expandable metallic stent placement, 915 NSAID vs. celecoxib effects on, 135 upper endoscopic ulcers, NSAIDs vs. celecoxib as cause, 733 once-weekly alendronate and NSAID tolerability, 158 rofecoxib vs. NSAID safety profile, 735 tolerability of celecoxib vs. NSAIDs, 736 Gastroparesis demographics, etiology, and clinical features in, 157 diabetic vs. idiopathic, symptoms and outcome comparison, 156 drug-refractory, gastric electrical stimulation and, 853 gastric electrical stimulation efficacy, 145 gastric electrical stimulation for, health-related quality of life after, 171 gastric emptying as predictor of management, 159 gastric neurostimulator, electrode location role in symptom control, 613 idiopathic, long-term outcome, 708 Gastropathy, nodular antral, in cirrhosis, 446 Gastroplication endoluminal, failed surgical fundoplication as indication of, 646 endoluminal anesthesiologist impact on, 932 configuration technique comparison, 89 gastroesophageal reflux disease efficacy, 34 refractory GERD effects, 96 Gastroscopy emergent transnasal, in upper GI bleeding, evaluation and assessment role, 901

AJG – Vol. 97, No. 9, 2002

sedation effects on anxious patients, 876 stress reduction through instrumental music in, 893 stress reduction through meditation, 892 Gastrostomy, percutaneous endoscopic, feeding tube placement, safety in patients 90 years of age and older, 587 Gastrostomy tube esomeprazole administration through, 9 esomeprazole delivery through, 55 Gatifloxacin, hepatotoxicity induced by, case report, 442 Gender consideration, gastric acid secretion, 119 Genomic analysis, long-segment Barrett’s esophagus, 24 GER: see Gastroesophageal reflux GERD: see Gastroesophageal reflux disease Giardiasis, duodenal nodular lymphoid hyperplasia caused by, in immunoglobulin A deficiency, 642 Gilbert’s syndrome, as cause of jaundice in hypertrophic pyloric stenosis, 264 Glutaraldehyde, colitis induced by, presenting as ischemic colitis, 438 Glycemic control, gastroparesis in diabetic hemodialysis patients, 117 Glycoconjugate, salivary, secretion of, reflux esophagitis and, 81 Graft versus host disease after orthotopic liver transplantation, 565 lymphoproliferative disorder and, after orthotopic liver transplantation, 627 Granulocyte colony-stimulating factor, mercaptopurine-induced leukopenia in Crohn’s disease and, 579 Hair growth, in hypopharynx, 381 Health care costs chronic hepatitis B, treatment costs and medical conditions resulting from, Canada, 317 proton pump inhibitor utilization and costs, pharmacy preference impact on, 698 upper gastrointestinal bleeding, Canadian hospitals, 925 Health care providers gastrointestinal fellowship intraining examination, 721 hepatitis C management guidelines understanding, survey in community hospital, 278 hepatitis C prevalence in, 291 Health care quality, Barrett’s esophagus, outcomes study, 49 Health care seeking, gastroesophageal reflux disease in Pakistan, 32 Heart failure, congestive, achalasia as cause of, 595 Heart transplant, hepatitis C-infected donor heart in hepatitis B/hepatitis D infected recipient, 535 Heartburn meal-induced, ranitidine dose comparison study, 11 mechanical and chemical stimuli in, 115 nocturnal, primary care provider perceptions of, 707 omeprazole for prevention, comparison with placebo, 719 over-the-counter omeprazole use and effects, 699 physical activity and pharmacological intervention effects on, 136 rabeprazole effects in GERD, 76 severity, as predictor of GERD symptom severity, 105 treatment and response predictors, 107 Helicobacter pylori corpus inflammation induced by, PPI therapy mechanisms, 151 ELISA detection of, proteinuria effects on, 147 eradication before cardiovascular prophylaxis, 170 nutritional supplementation as antimicrobial in, 161 Okadella gastrococcus presence after, 153 peptic ulcer incidence after, 126 rabeprazole-based triple therapy, racial demographics effects on efficacy, 50 therapy comparison, 748 gastric electrical stimulation effects on symptoms, 169 IgG/IgA antibodies to, frequency and age distribution of, 131 infection Barrett’s esophagus and, 100 gastric antral metaplasia association with, 129

AJG – September, 2002

H2-receptor antagonist vs. PPI as adjuvant therapy in, 149 laboratory tests as predictor of, in intestinal metaplasia, 130 severity of dyspepsia assessment in children, 695 transnasal sample collection method in 13C-urea breath test, 165 management in GERD, primary care provider perceptions of, 707 prevalence in a community hospital, 154 treatment compliance, inner city population, 745 treatment in family members of gastric cancer patients, 177 upper gastrointestinal disorders prevalence and, minority veterans and, 17 Hematochezia from duodenum, superior mesenteric vein coil embolization as cause of, 610 in initial presentation of Wegener’s granulomatosis, 584 recurrent, Klippel-Trenaunay-Weber syndrome with hemihypertrophy as cause of, 684 Hematopoietic stem cell transplantation acute pancreatitis after, children, 184 myelogenous leukemia, lymphoid extramedullary disease of pancreas after, 192 Hemihypertrophy, Klippel-Trenaunay-Weber syndrome with, as cause of recurrent hematochezia, 684 Hemobilia, presenting as hepatic artery to vein fistula, after percutaneous liver biopsy, 544 Hemochromatosis, hereditary, hemosiderosis of terminal ileum mucosa and, 533 Hemoclips, bleeding control in biliary sphincterotomy, 649 Hemodialysis diabetic, gastroparesis in, correlation with glycemic control and hematocrit, 117 isolated colonic histoplasmosis in, 464 patients, hepatitis C prevalence in, 291 Hemoglobinopathy, hepatitis C and, management of, 298 Hemolytic-uremic syndrome, colonic stricture and perforation after, child, 675 Hemostasis, duodenal diverticular, endoclipping of bleeder and feeder, 425 Hemosuccus pancreaticus, diagnosis by EUS, 583 Hepatic abscess, as initial manifestation of Crohn’s disease, 518 Hepatic artery to vein fistula, presenting as hemobilia after percutaneous liver biopsy, 544 Hepatic mass, rare hypervascular, case report, 467 Hepatitis antituberculosis drug-induced, cytochrome P450 2R1 genetic polymorphism and susceptibility to, 267 autoimmune Caroli’s disease and, case report, 605 primary hepatic lymphoma presenting as, diagnostic difficulties, 652 clobenzorex-induced, case report from Mexico border, 624 fibrosing cholestatic, in HIV and HCV infection, 470 rofecoxib-induced acute, 678 Hepatitis A nonfulminant, acute renal failure and, 389 virus antibody prevalence in cirrhosis, 271 Hepatitis B chronic, treatment costs and medical conditions resulting from, Canada, 317 HIV and, hepatocellular carcinoma in, prevalence of, 486 parasitic infection and, 530 vaccine nonresponse and celiac disease, 232 Hepatitis C acute, PEG-interferon/ribavirin therapy effects, 573 acute pancreatitis associated with interferon/ribavirin therapy in, 195 arthropathy, interferon efficacy, 570 arthropathy associated with, without evidence of liver disease, interferon therapy response, 418 central nervous system and intestinal vasculitis associated with, 491 chronic herbal medication use, socioeconomic status as determinant of, 299 interferon alfa-2B, ribavirin, and amantadine therapy effects, 293 management in larger practices, 582

Subject Index to Abstracts

S331

pegylated interferon effects on thyroid dysfunction in, 266 Rebetron refractory, PEG-Intron/ribavirin effects, 312 treatment response rates of veterans in Brooklyn, 308 chronic liver disease and, interleukin 15 in, 269 cirrhosis secondary to, variceal bleeding in, 303 CT scan-guided liver biopsy for, cost effectiveness and safety, 256 family practitioner role in evaluation and treatment, 499 hemodialysis-dependent patients, bacterial infections after interferon alpha treatment, 495 hemoglobinopathy and, management of, 298 hepatic fibrosis and, interferon effects on, 283 hepatocellular carcinoma screening in clinic for, 276 high-risk sexual behavior not risk factor for transmission in low socioeconomic status patients, 302 HIV and, fibrosing cholestatic hepatitis in, 470 initial laparoscopic appearance as predictor of response to, 253 interferon therapy, Bell’s palsy as complication of, 634 interferon/ribavirin therapy for, racial differences in hemoglobin and neutrophil levels, 285 in liver transplantation, interferon alpha 2B and ribavirin therapy for, 287 management guidelines understanding, survey in community hospital, 278 mode of infection and hepatocellular carcinoma characteristics, 300 neopterin as marker of immune function in, 301 PEG-interferon and ribavirin effects, 272 PEG-interferon/ribavirin therapy effects in nonresponders to Rebetron, 288 PEG-Intron and ribavirin effects on, 254 prevalence in health care workers, blood donors, and cirrhotic and hemodialysis patients, 291 racial differences in neutrophil count in PEG-interferon/ribavirin treatment, 280 recurrent, in liver transplant recipients with renal failure, PEG-interferon effects, 290 thrombocytopenia as contraindication to ribavirin and interferon treatment, 706 Hepatobiliary neoplasia, multidisciplinary management of, 270 Hepatobiliary strongyloidiasis, case report in AIDS patient, 592 Hepatoblastoma, in adults, case report and literature review, 622 Hepatocellular carcinoma hepatitis C mode of infection and, 300 in HIV and hepatitis B, prevalence of, 486 matrix metalloproteinase inhibitor sensitivity and, 260 p53 gene and mismatch repair gene mutation status and outcome in, 265 pancreatis islet cell tumors and, long-term androgen use association with, 564 prognostic factors in Mexican cohort, 307 screening in large hepatitis C clinic, 276 Hepatoid carcinoma, of pancreas, 546 Hepatopathy, ischemic, delayed rise in serum bilirubin and, case series and literature review, 281 Hepatopulmonary syndrome, transjugular intrahepatic portosystemic shunt management of refractory hypoxemia in, 566 Hepatotoxicity, gatifloxacin-induced, case report, 442 Herbal medication, in chronic hepatitis C, socioeconomic status as determinant of, 299 Hernia, hiatal: see Hiatal hernia Herpes simplex, colitis, in immunocompetent patient with ulcerative colitis, 555 Hetastarch, endoscopic mucosal resection, comparison with saline injection, 879 Hiatal hernia, esophageal pH normalization and relation to, in Barrett’s esophagus, 111 Hiccups, benzodiazepine-induced, GERD predictive role, 101 Histoplasmosis as cause of duodenal obstruction as initial presentation of AIDS, 635 gastrointestinal, of stomach and colon, AIDS and, 396 isolated colonic, in hemodialysis patient, 464 Holmium laser lithotripsy, Bouveret’s syndrome management, 441 Hormone replacement therapy, bile lithogenicity and gallbladder emptying

S332

Subject Index to Abstracts

alterations in, postmenopausal women, 180 H2-receptor antagonist, as adjuvant in Helicobacter pylori infection, comparison with proton pump inhibitors, 149 Human immunodeficiency virus chronic diarrhea in, mesalamine effects, 357 colon cancer and, Budd-Chiari syndrome in, 416 colonic tuberculosis in, 371 compartmentalized evolution, gastrointestinal mucosa as site of, 365 hepatitis B and, hepatocellular carcinoma in, prevalence of, 486 hepatitis C and, fibrosing cholestatic hepatitis in, 470 portal hypertension due to hepatoportal sclerosis, 388 Hydrogen breath testing comparison of devices for, 231 fasting, correlation with chronic constipation severity, 323 with/without fiber, colonoscopy preparation adequacy evaluation, 335 Hydrothorax, hepatic, with ascites, management, 552 Hyperemesis gravidarum, total parenteral nutrition, carnitine deficiency in, 408 Hypergastrinemia, Zollinger-Ellison phenotype in absence of, 419 Hypernephroma, as cause of lower gastrointestinal bleeding, 596 Hyperparathyroidism, primary, celiac disease and, 440 Hyperplasia, duodenal nodular lymphoid, caused by giardiasis, in immunoglobulin A deficiency, 642 Hypertransaminasemia, cryptogenic, case report of woman with, 681 Hypopharynx, hair growth in, 381 Hypoxemia, refractory, transjugular intrahepatic portosystemic shunt management, in hepatopulmonary syndrome, 566 IBS: see Irritable bowel syndrome ICU: see Intensive care unit Ileal pouch-anal anastomosis, histologic grade of inflammation of FASFAS-ligand expression in, 825 Ileoanal pouches, Crohn’s disease and, limb ulcerations as predictor of, 821 Ileocolic intussusception, in osteogenesis imperfecta, case report and literature review, 468 Ileoscopy, terminal, current practices in, 898 Immune function, neopterin as marker of, in hepatitis C, 301 Immunoglobulin G/immunoglobulin A, antibodies to, frequency and age distribution of in Helicobacter pylori, 131 Immunomodulator therapy gastroduodenal Crohn’s disease and, 829 preoperative surgical outcome in patients receiving, in Crohn’s disease patients, 795 Immunosuppression, postoperative liver enzyme abnormalities, 626 Imuran, bioavailability in inflammatory bowel disease, pharmacokinetic equivalency analysis, 769 Indigocarmine, chromoendoscopy with, colorectal adenoma detection, 884 Infection, parasitic, hepatitis B and, 530 Inflammatory bowel disease altered serotonin signaling in, 834 bioavailability of Imuran therapy, pharmacokinetic equivalency analysis, 769 complementary and alternative medicine treatment for, 784 evaluation, wireless capsule endoscopy, ileoscopy, small bowel followthrough for, comparison study, 802 infliximab-induced eosinophilic pleural effusion in, 537 irritable bowel syndrome and, 865 mast cell activation and degranulation after physiological stress in, electron microscopy study, 779 mediastinal fibrosis in, 687 mucosal mast cell response to stress in, 772 mucosal vs. transmural process in, optical coherence tomography study, 780 NOD2 mutation in relatives of Crohn’s disease patients and, 754 psoriasis and, infliximab effects, 810 race and ethnicity impact on, 768 TNF genotypes, ASCA positivity, and phenotypes in, Hispanic patients, 812 VSL#3 effects in, 830 Infliximab

AJG – Vol. 97, No. 9, 2002

bone synthesis markers in Crohn’s disease, 819 as cause of pulmonary coccidioidomycosis, 475 colectomy prevention in ulcerative colitis, 501 Crohn’s disease and, clinical experience, 798 episcleritis associated with Crohn’s disease and, 458 extraintestinal manifestations of Crohn’s disease, 808 gastric Crohn’s disease efficacy, 581 gelatinase B and tenascin in mucosa of Crohn’s disease patients, 788 hospitalization and surgical procedures in fistulizing Crohn’s disease, 805 intestinal strictures/obstruction risk in Crohn’s disease, 776 liver function test effects, in primary sclerosing cholangitis, 213 maintenance therapy in fistulous Crohn’s disease, 786 peristomal pyoderma gangrenosum and, 796 pouch vaginal fistula closure with, 528 on psoriasis and inflammatory bowel disease, 810 refractory pouchitis and, 548 steroid-refractory ulcerative colitis, 504 stricture response to, in Crohn’s disease, 777 successful infusion in pediatric office setting, 785 Intensive care unit, gastric pH control in, pantoprazole effects, 141 Interferon acute pancreatitis associated with, in hepatitis C, 195 acute renal failure and minimal change disease and nephrotic syndrome secondary to, 380 in hepatic fibrosis and hepatitis C, 283 hepatitis C arthropathy and, 570 hepatitis C-associated arthropathy without evidence of liver disease, 418 Interferon/ribavirin therapy, hepatitis C, racial differences in hemoglobin and neutrophil levels, 285 Interleukin 15, hepatitis C and chronic liver disease and, 269 Intestinal bleeding, lower, colonoscopic localization in, medications effects on frequency, 356 Intestinal epithelial tight junction permeability, mesalamine effects on TNF-a-induced increase in, 826 Intestinal malrotation, in adults, case report and management, 615 Intestinal metaplasia adenocarcinoma and dysplasia incidence and, international study, 7 Helicobacter pylori infection predictors in, 130 prevalence in Barrett’s esophagus, 38 Intestinal perforation in Marfan’s syndrome, 686 in parastomal hernia, by migrated plastic biliary stent, 451 Intestinal permeability, gas chromatography for urinary sucralose detection and, 241 Intestinal polyps, incidence in cystic fibrosis, 326 Intestinal pseudoobstruction, chronic idiopathic, hyperbaric oxygen therapy effects, 540 Intraluminal impedance esophageal manometry and achalasia evaluation, 16 oropharyngeal dysphagia evaluation, 28 pH monitoring and, gastroesophageal reflux diagnosis, 404 Iron deposition, hepatic, transferrin saturation as marker for, 319 Iron therapy, discontinuation of, pseudomelanosis duodeni effects, 543 Irritable bowel syndrome after hours telephone calls, physician vs. patient perceptions, 713 colonic ischemia and, medical care patterns in, 850 with constipation, diarrhea in tegaserod-treated patients, 843 constipation-predominant, altered serotonin signaling in, 834 diagnostic testing value in, 693 diarrhea-predominant, symptoms, colonic motility and microbiological features after bacteriotherapy in, 847 durability of diagnosis of, 832 in employed U.S. population, 737 fructose intolerance in, 833 health care utilization and medical use in U.S., 855 health-related quality of life impairment, gender-specific predictors of, 861 high-fiber diet alone vs. combination with paroxetine effects, 835

AJG – September, 2002

inflammatory bowel disease and, 865 menstrual cycle, oral contraceptives, and symptoms in women with, 866 objective bowel composite score in, validation of, 839 pain experience in, 836 physical activity effects on health perception in, 859 post enteritis, natural history and psychological factors role in, 846 prevalence, symptoms, and health care seeking in, urban population in Pakistan, 840 prevalence and impact in the U.S., 854 prevalence and risk factors, population-based study, 860 psychosocial function in patients with, 857 reinoculation with probiotics and, 493 relaxation response in management of, 841 symptom burden and management of, 731 symptomatic differentiation with function constipation, 856 tegaserod and antidepressant drug tolerance in, 851 tegaserod effects on abdominal discomfort/pain in, 838 Ischemia colonic, irritable bowel syndrome and, medical care patterns in, 850 intestinal, seasonal variation lack for, 725 right colonic, as complication of colonoscopy, 636 ISIS 2302, safety and pharmacokinetic study, in Crohn’s disease, 761 Jaundice cholestatic, liver failure and, primary systemic amyloidosis presenting as, 569 Gilbert’s syndrome as cause of, in hypertrophic pyloric stenosis, 264 liver failure and, differential diagnosis and workup of, 414 montelukast-induced cholestatic, 679 obstructive, caused by migrating bullet, 630 Jejunal feeding, percutaneous endoscopic jejunostomy vs. endoscopic gastrostomy for, 868 Job’s syndrome, primary sclerosing cholangitis as presentation of, 459 Kidney transplantation, immunosuppressive therapy in, celiac disease remission and, 597 Klippel-Trenaunay-Weber syndrome, with hemihypertrophy, as cause of recurrent hematochezia, 684 Kommerell’s diverticulum, aberrant right subclavian artery associated with, EUS diagnosis, 578 Labetalol, liver failure induced by, liver transplantation effects, 638 Lactobacillus reuteri, GI tract immunomodulation by, 229 Lactose maldigestion, breath hydrogen testing devices, comparison of, 231 Lactulose, pneumatosis cystoides intestinalis induced by, case report, 598 Lansoprazole age correlation with effectiveness, in esophagitis, 43 asthma exacerbations and quality of life in acid reflux and, 39 oral vs. intravenous, gastric acid secretion suppression, 155 Laparoscopy, gastric electrical stimulation placement for gastroparesis, comparison with laparotomy, 752 Laparotomy, gastric electrical stimulation placement for gastroparesis, comparison with laparoscopy, 752 Laryngopharyngeal sensory testing, laryngoscopy diagnostic yield in proximal GERD, 35 Laryngoscopy, laryngopharyngeal sensory testing effects on diagnostic yield, in GERD, 35 Leukemia myelogenous, after hematopoietic stem cell transplant for, lymphoid extramedullary disease of pancreas after, 192 T cell, HTLV-1 infection and, colonic malakoplakia in, 671 Leukoencephalopathic syndrome, posterior reversible, Crohn’s disease and, 474 Leukopenia with fever, due to mercaptopurine, induction of remission in Crohn’s disease, 790 mercaptopurine-induced, in Crohn’s disease, granulocyte colony-stimulating factor role in, 579 L-glucose, as colon cleansing agent before colonoscopy, 869 Ligation, endoscopic band, gastric varices, 120 Linitis plastica, of esophagus, case report, 442

Subject Index to Abstracts

S333

Lipase deficiency, failure to thrive and, 648 Lipoma, duodenal, bleeding, diagnosis and management, 397 Liver acute fatty, of pregnancy, diagnosis of, 674 parasitic infection of, 530 secondary amyloidosis of, as primary manifestation of Crohn’s disease, 488 Liver abscess, diarrhea and, as initial manifestations of ulcerative colitis, 427 Liver biopsy CT scan-guided, for hepatitis C, cost effectiveness and safety, 256 methods of, gastroenterologists in U.S., 318 percutaneous, hepatic artery to vein fistula presenting as hemobilia after, 544 transjugular, analysis of 650 procedures, 289 Liver cirrhosis acute abdomen in, PEG-interferon alpha 2B therapy and, 590 nodular antral gastropathy in, 446 Pasteurella multocida as cause of spontaneous bacterial peritonitis and empyema in, 604 Liver compromise, in amyloidosis, alkaline phosphatase, triglyceride, and cholesterol levels as indicator of, 284 Liver damage, endotoxemia and tumor necrosis factor in alcoholic liver disease and, 277 Liver disease acute, transjugular liver biopsy for, analysis of 650 procedures, 289 advanced, with liver mass, EUS-guided fine-needle aspiration vs. truecut biopsy in, 305 alcoholic, endotoxemia and tumor necrosis factor in, liver damage and, 277 autoimmune overlap syndrome in, treatment options for, 306 Budd-Chiari syndrome in antiphospholipid syndrome, mesoatrial shunt management, 609 chronic, hepatitis C and, interleukin 15 in, 269 metastatic, biliary stenting and cryosurgical/radiofrequency ablation in, 202 nonalcoholic fatty, normal alanine aminotransferase and, 268 progression in adults with cystic fibrosis, 255 Liver enzyme abnormalities of, postoperative, in immunosuppressed adult, 626 abnormalities of, in long-term total parenteral nutrition, 481 Liver failure acute, angiosarcoma presenting as, 654 cholestatic jaundice and, primary systemic amyloidosis presenting as, 569 Fusobacterium necrophorum sepsis presenting as, 577 jaundice and, differential diagnosis and workup of, 414 labetalol-induced, liver transplantation effects, 638 nonacetaminophen-induced, N-acetylcysteine in, children, 261 tizanidine-induced, high-dose steroid therapy for, 448 Liver function tests infliximab effects in primary sclerosing cholangitis, 213 results in acute biliary pancreatitis, 193 Liver mass, in advanced liver disease, EUS-guided fine-needle aspiration vs. true-cut biopsy in, 305 Liver transplantation anastomotic strictures after, ERCP evaluation and management role, 282 catatonia after, electroconvulsive therapy, adolescent, 433 cholesterol ester storage disease and, 522 hepatitis C in, interferon alpha 2B and ribavirin therapy for, 287 labetalol-induced liver failure and, 638 orthotopic graft versus host disease after, 565 graft versus host disease and lymphoproliferative disorder after, 627 for primary sclerosing cholangitis, cholangiocarcinoma in remnant duct after, 619 recurrent hepatitis C in, PEG-interferon effects, 290 recurrent nonalcoholic steatohepatitis after, pioglitazone treatment, 633 screening and preventive strategies in, Canada, 709

S334

Subject Index to Abstracts

tacrolimus immunosuppression, food allergy with villous atrophy after, children, 262 Lye ingestion, Barrett’s esophagus and, 527 Lymphangiomas, of GI tract, case reports, 523 Lymphoma colonic, presenting as diminutive colonic polyp, 519 hepatic B cell, presenting as cholangitis, 683 primary colonic, case reports, 479 primary hepatic, presenting as autoimmune hepatitis, 652 splenic, as cause of refractory diarrhea, octreotide and chemotherapy response, 663 Lymphoproliferative disorder, graft versus host disease and, after orthotopic liver transplantation, 627 Malabsorption, cholecystokinin deficiency-related, treatment in boy with autoimmune polyglandular syndrome, 413 Malakoplakia, colonic, in adult T cell leukemia and HTLV-1 infection, 671 Malignancy, extraluminal, EUS-guided fine-needle aspiration diagnosis, 903 Malnutrition, surgery risks in chronic pancreatitis, 216 MALT lymphoma, colonic, presenting with iron deficiency anemia, 387 Manometry decreased contractility in GERD evaluation, 88 esophageal clinical utility of, 68 gastroenterologist adherence to guidelines in use, 56 intraluminal impedance and, achalasia evaluation, 16 in nonobstructive dysphagia, 113 wet swallows as sample of esophageal motility, 5 Marfan’s syndrome, polypectomy and perforation in, 686 Mast cells activation and degranulation after physiological stress in inflammatory bowel disease, electron microscopy study, 779 mucosal, response to stress in inflammatory bowel disease, 772 Matrix metalloproteinase inhibitor, sensitivity, hepatocellular carcinoma and, 260 Medial arcuate ligament syndrome, diagnostic criteria and pathophysiology, 510 Mediastinal lymph nodes, EUS-guided fine-needle aspiration biopsy, 914 Medicare colorectal cancer screening methods in, 343 colorectal procedures in recipients of, 696 reimbursement and, 697 Meditation, stress reduction in gastroscopy and, 892 Melanosis duodeni, case report and literature review, 571 Menstrual cycle, women with irritable bowel syndrome, 866 Meperidine, cardiopulmonary complications of, comparison with fentanyl, 923 6-Mercaptopurine anastomotic site recurrence prevention, after ileocolic resection for Crohn’s disease, 778 azathioprine and, dose response and metabolism in lymphoblast cell line, in Crohn’s disease, 806 Merkel cell carcinoma, colonic and gastric metastases from, as cause of gastrointestinal bleeding and anemia, 460 Mesalamine chronic diarrhea in HIV, treatment effects, 357 once daily vs. conventional disease, quiescent ulcerative colitis effects, 704 Mesenchymal tumors, gastrointestinal, 432 Mesenteric vein thrombosis, colonic varices as presentation of, 463 Mesocaval shunt, migration through bowel wall and passing through ileostomy after 18 years in situ, 529 Metabolic acidosis, systemic vasculitis presenting with abdominal pain and, 497 Metaplasia Barrett’s: see Barrett’s metaplasia gastric antral, association with Barrett’s esophagus and Helicobacter pylori, 129 intestinal: see Intestinal metaplasia

AJG – Vol. 97, No. 9, 2002

Methadone, asymptomatic common bile duct dilation and, 219 Methemoglobinemia, after topical benzocaine, 664 Methicillin-resistant Staphylococcus aureus, colitis associated with, presentation and etiology, 606 Methylprednisolone, in Crohn’s disease, comparison with budesonide, 799 Mirizzi’s syndrome, pancreatitis and, evolving into cholecystoduodenal fistula, 601 Monoclonal antibody, metaplastic changes in gastric polyps, 338 Montelukast, cholestatic jaundice induced by, 679 Mortality, after PEG tube placement, factors leading to, 727 Motility esophageal: see Esophageal motility preoperative, laparoscopic antireflux surgery and, 46 Motility disorders, gastrointestinal, autonomic/enteric nervous system evaluation effects on therapy, 174 MRSA: see Methicillin-resistant Staphylococcus aureus Mucinous tumor, intraductal papillary as manifestation of Peutz-Jeghers syndrome, 551 pancreas divisum and, as cause of recurrent pancreatitis, 632 Mucosal prolapse syndrome, differentiation from rectal cancer, 490 Mucosal resection, endoscopic gastric cancer, outcome study, 134 hetastarch vs. saline injection for, 879 Muscular dystrophy, exocrine pancreatic insufficiency and, in father and daughter, 403 Mycobacterial infection Crohn’s disease and, skin testing for evaluation of association between, 813 mimicking erythema nodosum, in patient with Crohn’s disease on infliximab therapy, 800 Mycobacterium avium intracellulare, Whipple disease and, endoscopic differentiation and pathologic similarity, 434 N-acetylcysteine, in nonacetaminophen-induced liver failure, children, 261 Nasoenteric feeding tubes, endoscopic vs. fluoroscopic placement of, 936 Nasogastric tubes esomeprazole administration through, 9 esomeprazole administration effectiveness, 69 esomeprazole delivery through, 55 Nasojejunal feeding tubes, placement technique, 878 Nausea, EGG and water load test for differentiation from bloating, 128 Necrosis ischemic, of bilateral tibia and fibula in Crohn’s disease, 469 warfarin-induced esophageal, 676 Neoplasia colonoscopy for detection of, gender/age implications, 346 colorectal chromoendoscopy and magnification for detection of, in ulcerative colitis, 767 prevalence in breast cancer patients, 347 Neopterin, as marker of immune function in hepatitis C, 301 Neostigmine, colonic pseudoobstruction treatment effects, 337 Neurostimulator, gastric, electrode location role in symptom control, 613 NOD2 gene, in familial Crohn’s disease, clinical manifestations in, 794 Nonsteroidal antiinflammatory drugs colorectal carcinoma prevention and, 710 gastric cyclooxygenase inhibition, comparison study, 172 gastroduodenal ulcer prophylaxis, 742 gastrointestinal bleeding risks and, 168 GI safety, comparison with celecoxib, 135 NSAID: see Nonsteroidal antiinflammatory drug Nutritional supplementation, allium, Helicobacter pylori eradication effects, 161 Obliteration, retrograde transvenous, gastric fundal varices management, 160 Octreotide, long-acting release, intractable diarrhea and abdominal pain in short bowel syndrome and, 456 Ogilvie’s syndrome Corynebacterium jeikeium-induced sepsis and, in leukemic patient, 511 recurrent, percutaneous endoscopic cecostomy for, 531

AJG – September, 2002

Okadella gastrococcus, after Helicobacter pylori eradication, 153 Omeprazole erosive esophagitis symptom duration impact on severity and, 58 esophageal acid exposure in GERD, comparison with rabeprazole, 74 heartburn prevention, comparison with placebo, 719 over-the-counter, use and effects for heartburn, 699 Optical coherence tomography study, mucosal vs. transmural process in inflammatory bowel disease, 780 Ornithine decarboxylase, sporadic adenomatous colonic polyps and, 344 Orocecal time, in chronic constipation, 226 Osteoarthritis, gastrointestinal tolerability of aspirin and rofecoxib or naproxen, 717 Osteogenesis imperfecta, ileocolic intussusception, case report and literature review, 468 Ostomates, outcome and function in, factors affecting, 714 Otalgia, meal-induced dysphagia and, secondary to pyriform sinus fistula, 575 Oxygen therapy, hyperbaric chronic idiopathic intestinal pseudoobstruction, 540 for pneumatosis cystoides intestinalis, 240 p27 expression, in Barrett’s esophagus, association with adenocarcinoma, 12 p53 gene, mismatch repair gene mutation and, outcome in hepatocellular carcinoma, 265 Pain, in irritable bowel syndrome, 836 Pancreas acinar cell carcinoma, EUS role in detection, 567 adenocarcinoma duodenal sarcoma presenting as, 407 traumatic abdominal pain and CA19 –9 role in concealing diagnosis, 568 annular, as cause of acute pancreatitis, 411 ascites, presentation in infant, 580 cancer age effects on body/tail lesions and metastatic disease, 203 EUS-guided fine-needle aspiration diagnostic accuracy and complication assessment, 196 focal polyarteritis nodosa mimicking, 647 exocrine insufficiency, muscular dystrophy and, in father and daughter, 403 hepatoid carcinoma of, 546 intraductal papillary-mucinous tumor of, ultrasonography for differential diagnosis of, 194 lymphoid extramedullary disease, after hematopoietic stem cell transplant in myelogenous leukemia, 192 pseudoaneurysm, penetrating in stomach and hemosuccus pancreaticus, as cause of GI bleeding, 494 pseudocysts of, EUS-guided needle drainage of, 214 pseudopapillary tumor of, presenting with acute pancreatitis, 496 Pancreas divisum biliary tract malignancy associated with, 208 intraductal papillary mucinous tumor and, as cause of recurrent pancreatitis, 632 ventral calcific pancreatitis in, 612 Pancreatectomy, efficacy in primary sclerosing pancreatitis, long-term outcome study, 218 Pancreatic disease, ERCP and EUS for evaluation of, 211 Pancreatic function test, endoscopic, with porcine secretin, for chronic pancreatitis evaluation, 204 Pancreatic islet cell tumors, hepatocellular carcinoma and, long-term androgen use association with, 564 Pancreaticoduodenectomy, Whipple’s, celiac disease diagnosis after, 457 Pancreatitis acute abdominal CT for evaluation of, 182 after hematopoietic stem cell transplantation, children, 184 annular pancreas as cause of, 411 bacterial infection, alcohol intake effects on, 224 cerulein-induced, vitamin C/E supplementation abrogation of, 197

Subject Index to Abstracts

S335

complication of familial adenomatous polyposis, 594 elemental diet effects on trypsin synthesis and turnover in, 223 interferon/ribavirin therapy in hepatitis C association with, 195 primary sclerosing cholangitis presenting as, 482 pseudocyst formation in, 210 pseudocysts in, conservative vs. early surgery for management of, 198 pseudopapillary tumor of pancreas presenting with, 496 biliary, acute, liver function test results in, 193 chronic common bile duct strictures in, endoscopic management of, 217 endoscopic pancreatic function test with porcine secretin for evaluation of, 204 malnutrition effects on surgery risks, 216 as manifestation of cystic fibrosis, 588 chronic pain of, epinephrine with celiac plexus medications effects, 178 ERCP, allopurinol role in prevention, 921 Mirizzi’s syndrome and, evolving into cholecystoduodenal fistula, 601 post-ERCP lidocaine spray on ampulla of Vater effects on incidence, 190 volume expansion for prevention of, 187 primary sclerosing, pancreatectmy efficacy, long-term outcome study, 218 recurrent, intraductal papillary mucinous tumor and pancreas divisum as cause of, 632 refractory acute, as initial manifestation of small cell lung cancer, 651 risks in Crohn’s disease, 689 sclerosing autoimmune, EUS findings in, 506 ventral calcific, in pancreas divisum, 612 Pancreatobiliary malignancy, CA19 –9 reliability as marker of, 487 Pantoprazole gastroesophageal reflux disease and, comparison with esomeprazole, 60 intermittent IV, gastric pH control in ICU patients, comparison with continuous cimetidine, 143 pentagastrin-stimulated gastric acid secretion inhibition, 148 Papillary stenosis, refractory celiac disease of ampulla of Vater as cause of, 431 Parasitic infection, hepatitis B and, 530 Parenteral nutrition, total electrolyte patterns and liver enzyme abnormalities in, 481 hyperemesis gravidarum, carnitine deficiency in, 408 Pasteurella multocida, as cause of spontaneous bacterial peritonitis and empyema, in cirrhosis, 604 Patient satisfaction, endoscopy procedures, 749 PEG tube placement mortality and low satisfaction after, factors leading to, 727 multidisciplinary approach to, 724 over-the-guidewire, technique modification, 870 PEG-interferon/ribavirin therapy, weekly, comparison with daily interferon-alpha 2B/ribavirin therapy, 316 PEG-interferon recurrent hepatitis C in liver transplantation and, 290 ribavirin and, in hepatitis C virus, 272 PEG-interferon alpha 2B therapy, acute abdomen in liver cirrhosis and, 590 PEG-interferon/ribavirin therapy acute hepatitis C and, 573 effects in nonresponders to Rebetron, hepatitis C, 288 in hepatitis C, 254 in Rebetron refractory chronic hepatitis C, 312 Pegylated interferon, thyroid dysfunction in chronic hepatitis C, 266 Pelvic floor dyssynergia, balloon expulsion and defecation index, 858 Pentagastrin, gastric acid secretion stimulated by, pantoprazole inhibition of, 148 Pepsin, gastrin role in regulation of, 79 Pepsinogen gastric cancer screening effects, 137 gastric cancer screening efficacy, 139 Peptic ulcer emotional stress as cause, 127 incidence after cured Helicobacter pylori infection, 126 Peptic ulcer disease

S336

Subject Index to Abstracts

Helicobacter pylori infection and, nutritional supplementation as antimicrobial in, 161 Helicobacter pylori-negative, incidence of, 166 Peritonitis bacterial, spontaneous, incidence, characteristics, and outcomes, 292 spontaneous bacterial, empyema and, Pasteurella multocida as cause of, in cirrhosis, 604 vancomycin-resistant enterococci spontaneous bacterial, case report, 614 PET: see Positron emission tomography Peutz-Jeghers syndrome gastric outlet obstruction as presentation of, 465 intraductal papillary mucinous tumor as manifestation of, 551 quality of life measures in, 245 pH monitoring 24 hour gastroenterologist adherence to guidelines in use, 56 integrated acidity measures, age/gender influence on, 119 catheter-free, 103 clinical utility of, 68 esophageal acid exposure assessment, diagnostic yield, 29 GERD symptoms and, as predictor of pharyngeal reflux, 90 intragastric, esomeprazole effects on, 61 intraluminal impedance and, gastroesophageal reflux diagnosis, 404 Pharyngeal reflux, GERD symptoms and pH monitoring as predictor of, 90 Photodynamic therapy in Barrett’s esophagus, telomerase and, 104 esophageal dysmotility in Barrett’s esophagus and, 70 intraductal, biliary papillomatosis treated with, 625 salvage, after radiation therapy for esophageal cancer, 51 Physical activity health perception in irritable bowel syndrome, 859 heartburn severity and, 136 Pineal gland germinoma, metastasis through ventriculoperitoneal shunt, abdominal pain and GI bleeding as presentation of, 677 Pioglitazone, recurrent nonalcoholic steatohepatitis after liver transplantation and, 633 Pleural effusion infliximab-induced eosinophilic, in inflammatory bowel disease, 537 pancreaticopleural fistula as cause of, 400 Pneumatosis coli, cryptosporidiosis of GI tract and, AIDS patients, 513 Pneumatosis cystoides intestinalis hyperbaric oxygen therapy for, 240 lactulose-induced, case report, 598 Pneumobilia, duodenal obstruction and, intestinal strongyloidiasis presenting with, 645 Pneumoencephalomeningitis, Crohn’s disease and, 492 Polyamines, sporadic adenomatous colonic polyps and, 344 Polyarteritis nodosa, mimicking pancreatic cancer, 647 Polyglandular syndrome, autoimmune, cholecystokinin deficiency-related malabsorption treatment in boy with, 413 Polypectomy, in Marfan’s syndrome, 686 Polyposis familial adenomatous: see Familial adenomatous polyposis gastric, cecal polyp and, as cause of iron deficiency anemia, 391 Polyps colonic colonic lymphoma presenting as, 519 diverticulosis and, association between, 336 large, office-based polypectomy safety and efficacy, 917 risks in erosive esophagitis, 349 sporadic adenomatous, polyamines and ornithine decarboxylase role in, 344 Strongyloides stercoralis presenting as, 621 colorectal screening implications, racial variations in, 744 smoking as predictor of, 350 ursodeoxycholic acid role in prevention, 358 fundic gland, Barrett’s esophagus incidence in, 167 gastric monoclonal antibody for determination of metaplastic changes in, 338

AJG – Vol. 97, No. 9, 2002

treatment and outcome at university medical center, 138 hyperplastic, resected tubular adenomatous polyp regrowing as, 466 ileal, gastrointestinal bleeding from, 623 tubular adenomatous, resected, regrowing as hyperplastic polyp, 466 Portal hypertension cyclooxygenase and nitric oxide synthase regulation after nitric oxide synthase inhibition in, 310 due to hepatoportal sclerosis in HIV, 388 gastric fundal varices in, retrograde transvenous obliteration for management, 160 portal vein aneurysm, portosystemic venous fistula, and, 536 Portal vein aneurysm, portosystemic venous fistula, portal hypertension, and, 536 Portal vein thrombosis, incidence and etiology of, five-year cohort study, 294 Positron emission tomography, incidental, significance in gastrointestinal tract, 250 Pouchitis refractory, infliximab efficacy in, 548 in ulcerative colitis, clinical and histologic predictors of, 820 PPI: see Proton pump inhibitors Prednisone, intractable vomiting resolution and, 691 Pregnancy acetaminophen overdose in, case report and literature review, 559 acute fatty liver of, diagnosis of, 674 gastroesophageal reflux disease presentation in, 82 severe colitis, management and outcome, 824 Probiotics reinoculation with, irritable bowel syndrome and, 493 VSL#3, inflammatory bowel disease and, 830 Proctitis, isolated, schistosomiasis as cause of, 439 Progesterone, retroperitoneal fibrosis and, 562 Propofol for gastrointestinal endoscopic procedures, comparison with meperidine and midazolam, safety and efficacy study, 753 sedation for gastrointestinal endoscopy, comparison with conscious sedation, 911 Prostaglandin, expression, as indicator of growth and invasiveness of colon cancer, 345 Prostaglandin E2, production of, ursodeoxycholic acid effects on, in Barrett’s esophagus, 53 Proteinuria, ELISA detection of Helicobacter pylori infection and, 147 Proton pump inhibitors as adjuvant in Helicobacter pylori infection, comparison with H2-receptor antagonist, 149 carcinoma/dysplasia incidence in Barrett’s metaplasia and, 6 esophageal acid and bile exposure in Barrett’s esophagus, 66 gastroesophageal reflux disease symptoms efficacy, 48 Helicobacter pylori-induced corpus inflammation, mechanisms of, 151 intravenous effects on hospital mortality in upper GI bleeding, 702 inappropriate use of, 720 nonerosive GERD and, 718 reversal of pump inhibition, 140 utilization and costs, pharmacy preference impact on, 698 Pseudoaneurysm, pancreatic, penetrating in stomach and hemosuccus pancreaticus, as cause of GI bleeding, 494 Pseudocysts in acute pancreatitis, conservative vs. early surgery for management of, 198 formation in acute pancreatitis, 210 intraluminal pancreatic of duodenum, endoscopic therapy effects, 386 pancreatic, EUS-guided needle drainage of, 214 Pseudodiverticulosis, esophageal intramural, 424 Pseudodiverticulum, esophageal ring and, complicated by food bolus impaction, 394 Pseudomelanosis duodeni case report and literature review, 571 oral iron therapy discontinuation effects, 543 Pseudoobstruction, colonic, neostigmine for treatment of, 337

AJG – September, 2002

Pseudoxanthoma elasticum, as cause of gastrointestinal bleeding, 478 Psoriasis, inflammatory bowel disease and, infliximab effects, 810 Psychological considerations emotional stress as cause of peptic ulcer, 127 post enteritis irritable bowel syndrome, 846 Psychopathology, nutcracker esophagus and, 99 Psychosocial function, patients with irritable bowel syndrome, 857 Pulmonary nodules, azathioprine-associated, in Crohn’s disease, 690 Pylephlebitis, case reports and management, 405 Pyoderma gangrenosum peristomal, infliximab treatment, 796 of sternum, ulcerative colitis and, 560 Quality of life health-related gastric electrical stimulation for gastroparesis, 171 impairments in, in irritable bowel syndrome, gender-specific predictors of, 861 in Peutz-Jeghers syndrome, 245 Rabeprazole esophageal acid exposure in GERD, comparison with omeprazole, 74 evening vs. morning administration, esophageal acid exposure control and, 10 gastroesophageal reflux disease symptom reduction and, 726 GERD relapse preventive effects, 114 heartburn in GERD, 76 relapse prevention in erosive GERD, 110 safety and tolerability in erosive/ulcerative GERD, 106 salivary secretion preservation and, 77 Radiation therapy preoperative, enteral wall stent for obstructing rectal cancer, 653 rectal injury induced by, vitamins C and E effects in, 377 salvage photodynamic therapy after, in esophageal cancer, 51 Ranitidine, meal-induced heartburn control, dose comparison study, 11 Rectal injury, radiation-induced, vitamins C and E effects in, 377 Rectum adenocarcinoma, EUS predictions of, after preoperative brachytherapy, 919 cancer mucosal prolapse syndrome differentiation from, 4907 obstructing, enteral wall stent for, properative radiation and postoperative chemotherapy, 653 Rofecoxib, acute hepatitis induced by, 678 Reflux disease endoscopy-negative, treatment response predictors in, 36 nonerosive, esophageal motility effects on reflux in, 84 Reflux Symptoms Questionnaire, validity and reproducibility of, 743 Regurgitation symptoms, rabeprazole efficacy in, in erosive GERD, 47 Relaxation response, irritable bowel syndrome management and, 841 Remicade, examination under anesthesia in perianal Crohn’s disease effects on complications of, 817 Renal failure, acute minimal change disease and nephrotic syndrome secondary to interferon treatment, 380 nonfulminant hepatitis A and, 389 Resection endoscopic, gangliocytic paraganglioma involving ampulla of Vater, 593 endoscopically guided laparoscopic, gastric stromal tumors, 641 Rett’s syndrome, ulcerative colitis in patient with, 759 Ribavirin acute pancreatitis associated with, in hepatitis C, 195 PEG-interferon and, in hepatitis C virus, 272 PEG-Intron and, in hepatitis C, 254 Rumination syndrome, diagnosis and treatment challenges, 144 Salivary secretion, preservation of during rabeprazole administration, 77 Santorinicele, chronic abdominal pain and, 629 Sarcoidosis, Whipple disease masquerading as, 670 Satiety, drink testing, self-efficacy in, 831 Schatzki’s ring

Subject Index to Abstracts

S337

endoscopic therapy effects, 52 needle knife electrocautery safety and efficacy in, 92 Schistosomiasis, as cause of isolated proctitis, 439 Sclerosis, hepatoportal, portal hypertension due to, in HIV, 388 Sepsis Corynebacterium jeikeium-induced, Ogilvie’s syndrome and, in leukemic patient, 511 Fusobacterium necrophorum, presenting as liver failure, 577 Shunt congenital intrahepatic, case report and literature review, 420 mesoatrial, Budd-Chiari syndrome and in antiphospholipid syndrome, 609 transjugular intrahepatic portosystemic: see Transjugular intrahepatic portosystemic shunt ventriculoperitoneal, pineal gland germinoma metastasis through, abdominal pain and GI bleeding as presentation of, 677 Sigmoid colon, cancer, presenting as perianal mass due to sigmoidoanal intussusception, 665 Sigmoid diverticulum, giant, case report, 637 Sigmoidoscopy flexible colorectal carcinoma screening program, long-term follow-up study, 354 computer-assisted endoscopic skill assessment, 899 computer-assisted simulator for resident training, 890 screening, physician vs. nonphysician performance success, elderly patients, 933 portal venous gas embolism induced by, 449 Sildenafil, lower esophageal sphincter pressure effects, 102 Sleep disturbances in erosive esophagitis, esomeprazole effects, 95 in gastroesophageal reflux disease, 80 gastrointestinal disorders association with, 13 Small bowel adenoma of, villous atrophy and, 233 cervical cancer metastatic to, as cause of obscure gastrointestinal bleeding, 429 lymphangiomas of, case reports, 523 pathology, wireless capsule endoscopy assessment of, 920 perforation, gastrointestinal bleeding and, in Wegener’s granulomatosis, case report, 514 radiography, obscure gastrointestinal bleeding detection and, 246 sarcoidosis of, presenting as upper GI bleeding, 657 ulcer, detection by wireless capsule endoscopy in normal enteroclysis, 242 varices, capsule endoscopy diagnosis of, 234 Small cell lung cancer, refractory acute pancreatitis as initial manifestation of, 651 Small intestines immunoproliferative disease of, celiac disease presenting as, 401 lesion detection, video capsule endoscopy comparison with small bowel follow-through and abdominopelvic CT, 244 Smoking, as predictor of colorectal polyps, 350 Socioeconomic status, lower, high-risk sexual behavior not a risk factor for transmission of hepatitis C, 302 Spectrophotometry, endoscopic reflectance, duodenal mucosal defense mechanisms in smokers, 929 Sphincter pressure, esophageal, preoperative, as predictor of post fundoplication dysphagia, 67 Spleen rupture, after resuscitation for bleeding events in alcoholic cirrhosis, 673 wandering, gastric variceal bleed due to, 452 Sprue, collagenous, collagenous gastritis, collagenous colitis, and bacterial overgrowth syndrome and, 444 Steatohepatitis, recurrent nonalcoholic, after liver transplantation, pioglitazone treatment, 633 Stenosis, hypertrophic pyloric, Gilbert’s syndrome as cause of jaundice in, 264 Stent bioabsorbable self-expanding, long-term evaluation, porcine model, 200

S338

Subject Index to Abstracts

expandable metal, enterocutaneous fistula management, 554 metal, endoclips as anchors for, 430 migrated plastic biliary, intestinal perforation in parastomal hernia by, 451 self-expandable metal, role in colorectal malignancy, 874 Wilson-Cook Za, malignant biliary obstruction palliation effects, 188 Sternum, pyoderma gangrenosum of, ulcerative colitis and, 560 Stomach bleeding stromal tumor of, ablation with left gastric artery embolization, 471 lymphangiomas of, case reports, 523 Okadella gastrococcus after Helicobacter pylori eradication, 153 Stress, emotional, as cause of peptic ulcer, 127 Stricture lye, isolated segment of Barrett’s esophagus as complication of, 527 vascular, capsule endoscopy leading to localization of, 390 Stromal tumors, gastric, endoscopically guided laparoscopic resection of, 641 Strongyloides stercoralis, presenting as colonic polyps, 621 Strongyloidiasis hepatobiliary, case report in AIDS patient, 592 severe, clinicopathologic study, 236 Stuart-Bras syndrome, diagnosis of, 480 Subclavian artery, aberrant right, associated with Kommerell’s diverticulum, EUS diagnosis, 578 Sucralose, gas chromatography for detection of, intestinal permeability and, 241 Sulfasalazine ductopenic cholestasis induced by, in ulcerative colitis, 517 treatment for arthritis, as cause of eosinophilic colitis, 553 Superior mesenteric vein coil embolization, as cause of hematochezia from duodenum, 610 Surgery antireflux, laparoscopic gastroesophageal junction motility and function after, 22 preoperative evaluation impact on, 46 Roux-en-Y gastric bypass, anastomotic stricture development after, 164 Sweet’s syndrome, gastrointestinal endoscopic appearance of, 489 Technetium 99m-labeled bleeding scan, utility in evaluation of lower gastrointestinal bleeding, 366 Tegaserod abdominal discomfort/pain in irritable bowel syndrome, 838 antidepressant drugs and, tolerance in irritable bowel syndrome, 851 diarrhea in patients treated with, irritable bowel syndrome with constipation and, 843 Telomerase, Barrett’s esophagus, photodynamic therapy and, 104 Terminal ileum intubation, during colonoscopy, diagnostic value of, 897 mucosa, hemosiderosis of, hereditary hemochromatosis and, 533 signet cell adenocarcinoma of, in neurofibromatosis and Crohn’s disease, 620 Theophylline, chest pain of esophageal origin and, 14 Thrombocytopenia, hepatitis C and, as contraindication to ribavirin and interferon treatment, 706 Thrombosis celiac artery, manifesting as acute gangrenous cholecystitis, 618 hepatic portal and splenic vein, incidence and etiology of, five-year cohort study, 294 Thyroid disease, fracture risk in Crohn’s disease and, 757 TIPS: see Transjugular intrahepatic portosystemic shunt Tizanidine, liver failure induced by, high-dose steroid therapy for, 448 Toothpick ingestion, abdominal pain and, 685 Transferrin saturation, as marker for hepatic iron deposition, 319 Transjugular intrahepatic portosystemic shunt, management of refractory hypoxemia in hepatopulmonary syndrome, 566 Trauma, achalasia development after, 23 Triglycerides, as indicator of liver compromise in amyloidosis, 284 Tuberculosis colonic, in HIV, 371

AJG – Vol. 97, No. 9, 2002

intestinal, presenting as Crohn’s disease, 399 presenting as ascending colon mass, 672 Tumor necrosis factor, liver damage in alcoholic liver disease and, 277 Tumor necrosis factor-a´ , and receptor genotype/phenotype associations in Crohn’s disease, 758 Ulcer: see also specific site or type valdecoxib effects on complications, 904 Ulcerative colitis acetylsalicylic acid formulation profiles in, 818 bullous pemphigoid and, case report, 688 chronic, comparison with cocaine colitis, case report and literature review, 445 Coherin peptides effects on response and remission in, 765 colorectal neoplasia detection by chromoendoscopy and magnification, 767 corticosteroid-dependent, granulocyte adsorption apheresis as adjunct to conventional therapy, 781 endoscopic activity index for treatment choice and therapeutic effect evaluation in, 822 EUS utility in management of, 760 gastroduodenal involvement in, 628 granulocyte/monocyte apheresis in, clinical evaluation, 774 immunocompetent patient with, herpes simplex colitis in, 555 infliximab role in colectomy prevention, case reports, 501 liver abscess and diarrhea as initial manifestations of, 427 mucosal chemokine response in, 755 in patient with Rett’s syndrome, 759 pouchitis in, clinical and histologic predictors of, 820 pyoderma gangrenosum of sternum and, 560 quiescent medical regimen effects on adherence, 770 mesalamine dosage effects on adherence and outcomes, 704 steroid-refractory cytomegalovirus infection in, 783 infliximab effects, 504 sulfasalazine-induced ductopenic cholestasis in, 517 Ultrasound differential diagnosis of intraductal papillary-mucinous tumor of pancreas, 194 endoscopic: see Endoscopic ultrasound Urbanicity Helicobacter pylori treatment compliance, 745 irritable bowel syndrome, prevalence, symptoms, and health care seeking in, urban population in Pakistan, 840 Urea breath test, 13C, transnasal sample collection method in, for Helicobacter pylori detection, 165 Ursodeoxycholic acid colorectal polyps prevention, 358 inflammation and PGE2 production in Barrett’s esophagus and, 53 Valdecoxib, ulcer complications and, 904 Vancomycin, spontaneous bacterial peritonitis resistant to, case report, 614 Varices bleeding in cirrhosis secondary to hepatitis C, 303 outcome after endoscopic therapy, native vs. nonnative Americans, 751 esophageal: see Esophageal varices gastric: see Gastric varices Vasculitis central nervous system and intestinal, associated with hepatitis C, 491 cutaneous lymphocytic, of lower extremities, autoimmune cholangitis manifesting as, 273 systemic, presenting with abdominal pain and metabolic acidosis, 497 Ventriculoperitoneal shunt, pineal gland germinoma metastasis through, abdominal pain and GI bleeding as presentation of, 677 Vertebral fractures, prevalence in Crohn’s disease, 828 Videofluoroscopy, quantitative reporting scale development, 94 Vienna classification, familial vs. sporadic Crohn’s disease, 782 Villous atrophy

AJG – September, 2002

food allergy and, after liver transplantation with tacrolimus immunosuppression, children, 262 small bowel adenoma and, 233 Vitamin C/E, supplementation, cerulein-induced acute pancreatitis abrogation and, 197 Vomiting, intractable, prednisone-induced resolution of, 691 Waldenstrom’s macroglobulinemia, presenting as new-onset ascites, 524 Warfarin, esophageal necrosis induced by, 676 Water load test, EGG and, bloating vs. nausea differentiation, 128 Wegener’s granulomatosis severe hematochezia in initial presentation of, 584 small bowel perforation and gastrointestinal bleeding in, case report, 514

Subject Index to Abstracts

S339

Whipple’s disease masquerading as sarcoidosis, 670 Mycobacterium avium intracellulare and, endoscopic differentiation and pathologic similarity, 434 sarcoid-like presentation of, 515 without small intestinal involvement, case report, 507 Whipple’s pancreaticoduodenectomy, celiac disease diagnosis after, 457 Wilson-Cook Za stent, malignant biliary obstruction palliation effects, 188 Zofran and phenergren, long-term efficacy of, 867 Zollinger-Ellison phenotype, in absence of gastrinoma and hypergastrinemia, 419